Item 3. High-level segment (Thursday afternoon)

UN Web TV recording

Opening of the 67th session of the Commission on Narcotic Drugs<a href="https://www.unodc.org/documents/commissions/CND/CND_Sessions/CND_67/Documents/ECN72024_L6_advance_unedited.pdf">Outcome Document: High-level Declaration by the Commission on Narcotic Drugs on the 2024 midterm review, following up to the 2019 Ministerial Declaration</a>Chair: Welcome. Inform you that for the opening session of the HLS, there’ll be a video transmission of the proceedings from this Plenary into BR-A. The HLS will also be webcast on UN Web TV. Before I open, organisational matters that the CND must consider. Extended Bureau: 4 meetings to deal with organisational matters. Also discussed during the pre-session consultations held yesterday. Thanks colleagues in the Extended Bureau and Permanent missions in Vienna. Thanks to Miguel Camilo Ruiz Blanco of Colombia, Chair of 66th session. First item of the provisional agenda: Election of officers. CND opened its 67th session at the reconvened session. First Vice Chair: Bangladesh, Asia Pacific States. Second Vice Chair: Slovenia, Euro…. Third Vice Chair: Malta WEOG. Rapporteur: Colombia, GRULAC. Chair: Ghana, Africa Group. Chairing with support of Bureau and Extended Bureau. The provisional agenda and proposed organisational work for CND67 are in the documentation. [Chair recalls documentation relevant to organisational matters and provisional agenda and proposed organisation of work]. It is so decided. We will continue this agenda item on Monday for the regular session. Immediately after the opening segment, which will take place shortly, we will proceed with the general debate over the course of today and tomorrow. After the morning session, resume at 2:45 pm. And 7:30 PM for the evening session. Tomorrow, we will continue with the general debate at 10AM. And the last session will be at 7:30 PM until we exhaust the list of speakers. During the 2nd intersessional meeting of this year, the order of speakers was subject to drawing of lots. I’ll provide further details shortly. Organisation and chairing of the roundtables. Briefly outlining the organisation and chairing arrangements for the HLS roundtables in parallel with the general debate in the plenary. Themes agreed by CND resolution. Two roundtables: Taking stock: work undertaken since 2019 & The way forward: the road to 2029. Each roundtable is composed of a panel of 5 panellists nominated by regional groups. 1 by CSOs through the VNGOC. 2 speakers from UN entities. Each one is co-chaired by 2 reps of 2 regional groups. The roundtable discussion Taking stock: work undertaken since 2019, chaired by Bangladesh and Mexico. Tomorrow morning, from 10AM to 1PM, the roundtable discussion The way forward: the road to 2029, will be chaired by Germany and Slovenia. The roundtable discussions will take place in BR-A. The co-Chairs will prepare a summary of salient points. Summary is not negotiated. I now open the HLS. A profound sense of duty embraces us today as we reflect the journey since 2019. One of the most pressing challenges of our era: the world drug problem. The scourge of the drug problem knows no boundaries, millions of lives affected. Evident that no single entity or nation can confront this issue in isolation. As the world becomes more increasingly interconnected, collective response is essential, indispensable. Importance of collaboration. Sustainable solutions can only be forged through international collaboration and solidarity. We should not and cannot undermine multilateralism. We undertake the midterm review since 2019. Incumbent upon us not to only assess but reinvigorate our commitment to action. For this purpose, I launched the Pled4Action Initiative, seeking commitments towards the goals in the 2019 Ministerial Declaration. Eagerly anticipate the strong pledges from the high-level representatives here. As we look to the final review in 2029, let’s be cognisant of the gravity of our mission. Safeguarding communities, preserving humanity’s dignity, and the future of our youth. Approach this issue with compassion, determination, and commitment to action. Open, constructive, and inclusive dialogue, steeped in evidence-based approaches. Now to the formal opening. Before giving the floor to our guest, the President of the UNGA, I’d like to proceed with the adoption of the Outcome Document. CND decided to adopt this document. MS conducted intense negotiations in the intersessional period ahead of this HLS. The outcome of this is the document to be adopted. As the silence procedure was not broken, I take it the Commission is ready to adopt the document. I invite the HLS to adopt the document: High-level Declaration by the Commission on Narcotic Drugs on the 2024 midterm review, following up to the 2019 Ministerial Declaration. I see no objections. Outcome Document is adopted. Thank you for your cooperation and collaborative spirit in the preparation of this document. I invite the President of the UNGA.President of the UN General Assembly: Great pleasure returning to Vienna for the 67th session of CND. Extend my gratitude to the Chair of CND. Congratulate the Chair and Bureau on elections. Thanks to the UNODC Executive Director in implementing all commitments to address the global drug problem. My message to you today is that we need to supercharge our multilateral cooperation efforts. In every workstream. Including effectively tackling the world drug problem. Complex and multifaceted. Permeates every sector. Breeds corruption, terrorism and violence. 2016 UNGASS was an inestimable opportunity to assess achievements, challenges, and make additional commitments toward combating this scourge. Record level drug cultivation and consumption are beyond alarming. The geo-Political climate is fraught with crisis and conflict. WDP exacerbates existing challenges and conflicts, disproportionately harming those marginalised and vulnerable in our societies. Thoughts with those who have lost lives and loved ones to the global drugs pandemic [….].Lawlessness breeds trafficking. The most impoverished bear the heaviest burden as victims of drug abuse and trafficking. GLobal South endures the harshest consequences. Scourge is immense. No single nation can confront alone. We must shoulder the responsibility collectively, enhancing cooperation within the framework of SDGs. Both engagement with civil society, youth and affected communities; recognising links with other cycles of harm, such as poverty, abuse, and systemic disenfranchisement, critical to craft effective responses. Ferocious emergence of synthetic drugs, particularly fentanyl, must also be decisively tackled in our response to this ever widening crisis. Addressing WDP requires coordinated efforts to approach different dimensions holistically, including protecting human rights, sustainable development, health, as well as the fight against corruption and organised crime. Welcome the Ministerial Declaration adopted by CND, where MS evaluates implementation of commitments. Clear path forward and we must advance its implementation leading up to its final review in 2029. Commend Pledge4Action initiative and encourage you to take pledges towards a brighter future. In closing, cannot overemphasise the importance of reimagining multilateral cooperation to secure a better future for present and future younger generations. As part of this, highlighting implementation of drug commitments and the Summit of the Future are paramount. These processes call upon us to envision how multilateral cooperation can address current issues affecting present and future generations. Encourage you all to engage and follow preparations for the Summit. From New York to Vienna, efforts to integrate drug control issues in SDG agenda must be synergised and bolstered. We can build equitable, resilient and compassionate futures.UN Secretary General (video message): The CND is a vital platform for solutions to advance drug policy commitments. More crucial as challenges grow complex. Our world faces record numbers of drug use, deaths and illicit production of many drugs. This session creates an opportunity to address WDP through balanced responses and collective action, countering trafficking, investing in prevention, equal access to health and treatment, protecting human rights and dignity of everyone, through our common position on drugs, we commit to provide support as you work to tackle challenges of illicit drug markets. Put people first by ending stigma, discrimination, stressing prevention and rehabilitation, human rights of people who use drugs, expanding prevention, treatment programmes and health services. Promote SDGs and leave no one behind.UNODC: Delighted with high level engagement and strong participation. INcluding civil society partners. As you review the implementation of all international commitments, ground discussions in reality. The WDP is ever more complex and contributes to holding back SDG progress. Synthetic drugs have changed the landscape, making it easier to traffick and produce extremely potent and often lethal substances. Drugs like fentanyl are causing a record number of deaths. While clandestine labs are sprouting up in all corners of the world. This phenomenon has added to but not replaced the threat of traditional plant based drugs. Cocaine market is expanding and spreading violence – biggest seizures in recent years in port cities like Antwerp and Rotterdam. Meanwhile, drug production methods and trafficking models are evolving, smaller, more fragmented, and highly specialised and network criminal groups are cooperating across different segments of the supply chain. The Internet is growing as a marketplace for drugs, precursors and chemicals, and technologies. Drugs trade overlaps with conflict violence, and instability. The trade fans the flame of gang violence in Haiti, threatens order in Ecuador. Tandem with other criminal activities in Myanmar’s borders. Complex situations in the Middle east, from Syria, to Lebanon to Iraq are becoming more grave. WDP undermines lives, livelihoods. First line responders are losing their lives every day. Commitments in 2019 are still relevant. As you review them, focus on goals that unite you. Delighted to know you have adopted an Outcome Document despite challenging geopolitical context. The spirit of Vienna prevails. Multilateralism can work. Division breeds inaction and this is a time for action. Commend Chair for Pledge4Action initiative. Looking forward, emphasis areas where action is needed: 1) Right to health – people with DU disorders need access to treatment. Women face greater barriers which intersect with other barriers. Affects people in contact with the criminal justice system, humanitarian settings, people who inject drugs who are more likely to live with HIV and HCV. Drug use disorders amplify harms and risks associated with other disorders. We must close gaps in treatment and care. Approach problems with treatment not punishment. Focus on children too, and adolescentes, more likely to develop disorders than others. We develop collaboration with WHO on overdose prevention, HIV prevention, treatment, and care for people who use drugs in prison. We work with civil society to reach those at risk of being left behind. 2) Help farmers find livelihoods away from drug cultivation. Crucial in Afghanistan where 95% reduction of poppy cultivation without alternative sources of income – and in Latin America and SEA where cultivation increases. We need your support to generate more opportunities. Agile responses to disrupt drug markets. Criminal organisations should be targeted by their common characteristics. Profit motive and flow of money, cybertechnology, firearms and violence. More engagement with private sectors (chemical producers, transportation, tech, financial system). Threats and opportunities of AI. Monitoring darkweb. Avoiding traffickers exploiting machine learning. UNODC supports interdiction efforts. Adapt to new criminal models. 4) Vital importance of science, data, research and evidence. Over the past decade, CND placed 80 substances and precursors on international control. UNODC supports implementing scheduling, supporting laboratories, and UN Toolkit for Synthetic Drugs. We must keep up with the pace of criminal markets. UNODC strives to make global, reliable data available, including through WDR, regional and thematic reports, and cultivation surveys. We ended cooperation to address gaps (mainly in Africa, Asia, Caribbean and Pacific). 5) Urgent need for balanced and collective responses. No amount of policing will end the illicit drug market as long as there’s enormous demand. No amount of prevention, treatment and harm reduction will change the situation if (…) No country can secure borders alone. Timeless goal of Conventions: health and wellbeing. Global common ground when international cooperation is needed most. In times of division and tensions, importance of common framework. Conventions are flexible and can be adapted to our time and practices. CND can support implementation today. We can promote responses that protect rights without surrendering the security of our communities to drugs and traffickers. UNODC stands with you for a healthier, safer, more prosperous future. INCB: Mr Chair, and distinguished ministers excellencies ladies and gentlemen. This road to 2029. comprises recommendations in the ICD annual reports over the period from 2023. Policies in two key areas..Two key areas: First, promote availability of controlled substances while preventing diversion. Secondly, health and evidence based drug policy that take into account human rights and provide responses to drug criminality that are proportionate. INCB contribution takes stock of board efforts since 2019 in implementing conventions and addressing emerging challenges. Supporting states to accurately estimate needs. Modules and seminars. 2022 Annual Report entitled ‘No patient left behind: Progress…’ following up on recommendations in UNGASS Outcome Document. The Board annually reviews 600 estimates, processes over 100 for psychotropic drugs, and thousands of shipments. INCB recommended 25 chemicals for international scheduling since 2019, complementing the scheduling functions over the past 5 years the government’s use of an improved export notification online system for precursor chemicals has prevented the diversion of nearly two tonnes of pseudoephedrine preparations To address the challenges of diversion equipment. New initiatives to facilitate private-public partnerships to prevent diversion of specialised equipment. Our systems have prevented significant amounts of ATS and GBL trafficking. INCB established the GRIDS programme. Cooperation has assisted South Asia governments to identify and arrest dealers in dark web and similar trafficking operations in Europe. Over 250 recommendations published for practical guidance in booklets, self assessment booklets. The number of incidents communicated through the ION project increased to almost 80,000. Some of the concrete ways INCB works with MS to safeguard health and welfare. Stand at the midpoint of implementing SDGs and the 2030 agenda. First section of the INCB contribution outlines how INCB’s work in contributing to projects, particularly SDG3 and SG16. Frustration as a health professional because. Too many people continue to suffer. Lack of access to controlled medicines and preventable substance use disorders. Keep the health and welfare of people and communities at the heart of your deliberations. The Conventions and CND came about from concern to wellbeing and health. INCB pledges its support. WHO: Excellencies, distinguished delegates, dear colleagues and friends, The non-medical use of psychoactive drugs leads to nearly six hundred thousand deaths each year, largely due to viral hepatitis, HIV, and overdose. These deaths are largely preventable, with the use of evidence-based services for prevention, treatment, and harm reduction, in line with WHO and UNODC guidance. And while minimizing the harms related to non-medical use of controlled substances is important, many of them can play a vital role in patient care. Opioid analgesics and psychotropic medicines are indispensable for pain management, palliative care, and the treatment of mental, neurological and substance use disorders. However, access to these controlled medications remains largely inadequate – particularly in low- and middle-income countries. Additionally, many people who use drugs face barriers to accessing the care they need, and effective treatment is often not available or affordable. The lack of access is made worse by stigma and discrimination, as well as policies and laws that prioritize criminal sanctions over public health needs. It doesn’t have to be either-or. We can strike a balance between policies that protect people from the harms of drug use, while enabling access to treatment and care for those in need. WHO remains committed to working with the INCB, UNODC, Member States, civil society, and other partners to find solutions that protect health, are evidence-based, and grounded in human rights. Because health is a human right, and so is access to medicines and services to protect it. I thank you. OHCHR: I very much welcome the opportunity to address this Commission. At such a critical moment for global action on the world drug situation. After decades of following a largely punitive approach, we can see this simply is not working. Not by any metric. The number of people using drugs has sharply risen. Criminalization, including the use of the death penalty, has neither diminished drug use nor deterred drug-related crime. Instead, more and more lives ruined, not just by the use of drugs in itself, but also by the fallout of counterproductive policies. Mass incarceration; communities stigmatized, impoverished and plagued by violence; arbitrary detention; the escalation of lethal force that can descend into extrajudicial killings taking place with impunity. A list that goes on. Representing a roll-call of misery and violations of human rights. It does not have to be this way. We have the evidence of what works. And the means to implement it. With the 2024 mid-term review very much in mind, my Office issued a report last August on human rights challenges related to the global drug problem. Clearly setting out the serious human rights consequences of the “war on drugs”. And highlighting positive developments in the form of drug policy approaches that are health- and rights-centred. Approaches that do not resort to condemning people who use drugs as criminals. But, instead, view their situation through the lens of human dignity and rights. A number of countries have ventured down this path, applying an evidence-based harm reduction approach, and decriminalizing the use of some drugs. In Portugal and Switzerland, for example, decades of decriminalization of personal consumption and possession have lowered drug-use, overdoses and HIV infections. In Colombia, a new national drug policy is anchored in human rights and development. Focusing on improving the living conditions of communities that depend on the drug economy. Targeting prosecutions at those who benefit most from criminal activity while dismantling criminal networks. Pakistan ended capital punishment for drug-related offences last year. I urge all countries to embrace this positive shift to evolve their own approaches. Our report sets out recommendations on how to do this. Building on the International Guidelines on Human Rights and Drug Policy. We need inclusive and gender sensitive drug policies that ensure access, on a voluntary basis, to medical care, drug dependence treatment and harm reduction services. And which are designed, implemented and evaluated through processes that facilitate the meaningful engagement of people who use drugs, affected communities, youth and civil society organizations. We need urgent action to end discrimination in law enforcement against people of African descent, Indigenous Peoples and marginalized populations. And, as we revitalize efforts towards the 2030 Agenda, we must stop leaving behind people who use drugs, their families and affected communities. This means, as the Commission has recognised, investing in alternative development. We must also address the poverty, lack of opportunities, insecure environments – the whole range of underlying, structural, socioeconomic factors – that increase the risk of people using drugs or becoming involved in the drug trade. As for decriminalization of personal use, if well designed and implemented, this can also be a powerful instrument to ensure better protection of the rights of people who use drugs. Excellencies, colleagues, This mid-term review is a moment of great opportunity. For setting in motion the transformative change that is needed globally on drug policies. I welcome the renewed commitment to human rights in the High Level Declaration, adopted today, along with commitments to evidence-based policies, the mainstreaming of age and gender perspectives, and to the health of individuals, families and communities. In relation to the gaps that the Declaration identifies in meeting international commitments, I urge States, civil society and other stakeholders to implement the recommendations in my Office’s report. And to work with us and the broader UN human rights system to move forward together in embedding an approach to the world drug situation that is as humane as it is effective. Thank you. Item 3. High-level segment Chair: We will have one minute to allow the president of the General Assembly to leave. Please remain seated. Now let us move to agenda 3B – general debate. We have over 14x seats attended to the high level segment of the commission. With over 100 speakers. The commission has divided that the statements in the general debate should not exceed 5 minutes. I appeal to all the speakers that they strictly adhere to the speaking time, as also decided by the Commission, chairs of regional groups will be allotted the speaking time of seven minutes max. The Pledges4Action would also take place during our general debates. If you’re making a pledge, please read out your pledge or the end of your statement within the 5 minutes of speaking. Group 77 and China: In Vienna, the rates of commitment continue to work to address and counter the world drug problem. The group would like to express its appreciation for the commendable efforts of the chairperson and the secretariat for the preparation and organisation of the session. The group of 77 and China now welcomes the convening of the high level segment of the commission and expresses its support for the high level declaration of the CND and on the 2024 midterm review, following the 2019 ministerial declaration agreed by the member states. The group views this as a positive step forward. It is important for our joint commitment to address and counter the world drug problems, the group would like to express its appreciation for the work carried out in the negotiation process. The group also take a positive note of all initiatives and effects of its member states which contribute to the world to eh commission, in addressing the world drug problem is a common and shared responsibility that should be undertaken in a multilateral setting through effective concrete and increase subregional, regional and international cooperation based on integrated multidisciplinary mutually reinforcing balanced, scientific evidence base and comprehensive approach with a view to promoting group stresses the importance of international cooperation and has companies capacity building initiatives, programmes and activities, provision of equipment and technology and technical assistance, particularly for developing countries in an open, transparent and equitable way to allow them to have sufficient resources to address encountered the world drug problem. The group remains strongly convinced that the upholding alternative including supporting an effecting UN development system and avoiding creating and entering unilateral coercive measures and actions on the developing countries in accordance with international law and the charter of the UN is essential to proof solidarity international cooperating frame and the international cooperation framework and for the sustained stabilities to address and counter the world drug problem (….) the 1972 protocol, the Convention on psychotropic substances of 1971. The United Nations Convention against illicit trafficking of drugs and psychotropic substances of 1988 and other relevant international instruments constitute the cornerstone of the international drug control system. The group reaffirms its committed to ensuring that all aspect of the main reduction and related measures like reduction and related measures and international cooperation are addressed in full conformity with the purposes and principles of the charter of UN international law and Universal Declaration of Human Rights with full respect for the sovereignty and territorial integrity of states the principle of non-intervention internal affairs of other states or human rights, fundamental freedoms in the current dignity of all individuals and the principles of equal human rights and mutual respect among states. The group reiterates the efforts to achieve the sustainable development goals and effectively address a worldwide problem…and mutually reinforcing The growth nodes with great concern the persistent disparity some progress made in ensuring the access availability and affordability of controlled substances for medical and scientific purposes, particularly for pain relief and palliative care. The group urges all member states to take concrete actions to ensure access availability, availability and affordability of controlled substances for medical and scientific purposes and remove any imposed barriers. The group acknowledges that drug use disorders face challenges that should be addressed effectively through treatment, healthcare, rehabilitation and recovery. The group recalls the UN Declaration on the Rights of Indigenous Peoples and recognises the importance The group underscores the significance of the United Nations Declaration on the Rights of Indigenous Peoples, emphasising the need to support sustainable livelihoods for indigenous peoples and local communities affected by the illicit crop cultivation and drug trafficking. It highlights the importance of promoting domestic economic alternatives through long-term, inclusive, and sustainable development programs aimed particularly at those communities and regions vulnerable to illicit crop cultivation and drug-related activities in both urban and rural settings…..The group points out the detrimental effects of transnational criminal organisations on public security and societal well-being, advocating for a comprehensive approach to combat the spread of these activities. Concerns about the growing threats posed by synthetic drugs to the illicit drug market are raised, with a call for member states to prioritise addressing this challenge. The adverse environmental impacts and the broader consequences of drug-related activities are acknowledged, with a stress on the necessity of addressing these issues and their root causes. The group calls for ongoing support from the UNODC to assist member states in adopting integrated, multidisciplinary and evidence-based strategies to counter the WDP in line international drug control conventions and other intentional drug policy commitments. acknowledges the persistent, new, and evolving challenges in drug control, advocating for ambitious, effective, and possibly innovative actions within the framework of the international drug control conventions. Lastly, the group notes the conventions’ flexibility, allowing states to tailor national drug policies to their specific needs and priorities, reaffirming the principle of common and shared responsibility and adherence to international law. The group emphasises the need to integrate gender and age perspectives into drug-related policies and programs, focusing on the well-being and safety of individuals, families, communities, and society, with special attention to women, children, and youth. This includes promoting health and access to treatment. The group expresses concern over the lack of equitable geographical representation and the underrepresentation of developing countries in the UNODC…. on implementing this principle, the progress made, and suggestions for improving member state representation in the UNODC Secretariat. Furthermore, the group, including G77 and China, calls on the international community, especially developed countries, to provide necessary support to enhance efforts to address and counter the world drug problem, underscoring the importance of global cooperation and support. Group of African States: Chairperson, I have the honour to deliver this statement on behalf of the Africa Group. At the onset, the Africa Group aligns itself with the Statement of the Group of 77 and China. The Group extends its warm congratulations to H.E Ambassador Philbert Johnson, Permanent Representative of Ghana on his election as Chair of the 67th session of the CND as well as to other members of the Bureau on their election. We thank the UNODC Secretariat for the excellent preparations for this session and assure you of our full support. The Group further congratulates Ambassador Johnson for presiding over this important session tasked with conducting a stocktaking review of the progress made in the implementation of the 2019 Ministerial Declaration and conveys its gratitude for his tireless efforts and leadership in preparing for this High-Level Segment, including his constructive on behalf of Africa as the Chair of the CND, to reach a consensus on the Outcome Document and uphold the Vienna Spirit. The Group also expresses its support for the Chair’s innovative “Pledge4Action” initiative aimed at mobilizing commitment towards concrete and impactful actions to address and counter the world drug problem. Chairperson, The Group commends the Executive Director of the UNODC, Ms Ghada Waly, for her able leadership in guiding our efforts to address and counter the world drug problem. The Group also commends Ms Waly for the UNODC Strategic Vision for Africa 2030 and calls for sufficient funding of the Strategy. The Group further urges the UNODC, relevant partners and donors to provide sufficient financial and technical support to African countries, tailored to their needs and priorities, to ensure the successful implementation of the mandate of the Commission in pursuance of the SDG Agenda 2030 and 2063 AU Agenda. The Group emphasizes that addressing and countering the world drug problem is a common and a shared responsibility of all UN member states and reiterates its commitment to the 2009 Political Declaration and Plan of Action; the 2014 Joint Ministerial Declaration; the 2016 UNGASS Outcome Document and the 2019 Ministerial Declaration (as well as its 2024 Mid Term Review Outcome Document Chairperson, The Group notes with appreciation the efforts of the African Union to craft a Common African Position for the Mid-term Review of the 2019 Ministerial Declaration, drawing attention to the challenges faced by the continent to improve the health, security and socio-economic wellbeing of its people, and further welcomes the African Union Plan of Action on Drug Control and Crime Prevention (2019-2025) . The Group notes with grave concerns the persistent disparities on progress made in ensuring the availability, accessibility, and affordability of controlled substances for medical and scientific purposes, particularly for the relief of pain and palliative care. The Group urges all Member States, the UNODC, and the private sector, especially the pharmaceutical industry, to take concrete actions to ensure access, availability and affordability of controlled substances for medical and scientific purposes and remove any barriers in this regard. Chairperson, The Group is concerned over the interlinkages between drug trafficking and other forms of transnational organised crime including corruption, illicit financial flows, cybercrime, and terrorism and calls for enhanced sub-regional, regional and international cooperation, including technical assistance and capacity building for law enforcement agencies, to counter this scourge. Chairperson, The Group takes note of the decision to delete cannabis and cannabis resin from Schedule (IV) of the 1961 Convention and placing it under International Control in Schedule (1) based on the WHO recommendation, while we recognise that Member States shall have the right to further exercise domestic control in accordance with Article 39 of the 1961 convention in this regard. The Group expresses concern regarding the increasing threats caused by synthetic drugs and their impact on the illicit drug market and, urges all Member States to decisively tackle this challenge. The Group continues to note with concern the harmful effects of the increasing nonmedical use of pharmaceutical opioids including Tramadol and invites Member States to collect and share data to facilitate the consideration of placing of the substance under international control to prevent its diversion for illicit use while ensuring its access and availability for medical and scientific purposes. The Group also denounces the online illicit trafficking of drugs, especially on the Darknet and increased illicit trafficking in precursor chemicals and synthetic drugs. The Group urges Member States to effectively counter these new and emerging challenges. We reaffirm the role of the CND as the principal policy making body of the United Nations in drug control matters, and our support for the efforts of the relevant UN entities, especially the treaty-mandated roles of the INCB and the WHO. The Group commends the Executive-Director for ensuring equitable geographical representation and gender balance are fully incorporated in the recruitment policy of UNODC, particularly at the senior levels. In conclusion, we reaffirm our resolve to review in 2029 progress made in implementing all our international drug policy commitments and undertake to accelerate and improve their implementation in the period from 2024 to 2029. Group of Asia-Pacific States: Chair, ED, excellencies, delegates,etc. On behalf of the Asia Pacific group we thank and congratulate the chair. We congratulate other elected members. Extend full support to ED of UNODC and DG of UN Office in Vienna. We work together on collective efforts to tackle drug use. We affirm that UNODC is the principal entity to tackle drug related issues and the CND is the principal fora. We acknowledge with appreciation the adoption of high level declaration and note the work to prepare for this session. We affirm our belief that the world drug problem is a multifaceted challenge with a need for a multidisciplinary approach within the principle of common and shared responsibility. We recognize efforts of national authorities in law enforcement, criminal justice, health and education and recognize the provision of technical assistance for these authorities where necessary. We recognize efforts to counter the world drug problem through demand reduction, supply reduction, and through international collaboration through principles of UN charter and with respect for international law and sovereignty of states as well as principles of equal rights and respect among states. We recognize that efforts to counter the world drug problem and to achieve the 2030 Sustainable Development Goals are complementary and mutually reinforcing. We recognize the key drug control conventions as the cornerstone of the international drug control system, as well as the 2009 Political Declaration, 2014 Ministerial Declaration, 2016 UNGASS Outcome Document, and 2019 Ministerial Declaration. Group fully supports efforts to counter illicit cultivation, production, trafficking and drug supply and demand, as well as precursor chemicals. We note the need to strengthen interregional and international collaboration and exchange of information where appropriate. In the context of this mid term review we reflect on the achievements and challenges in these commitments from the 2019 Ministerial Declaration. We express with concern the threat of spread of amphetamine type stimulants, especially methamphetamine and new psychoactive substances and non scheduled precursors. We ensure we will work towards comprehensive access to treatment programs in compliance with control conventions. Chair: We will have one minute to allow the president of the General Assembly to leave. Please remain seated. Now let us move to agenda 3B – general debate. We have over 14x seats attended to the high level segment of the commission. With over 100 speakers. The commission has divided that the statements in the general debate should not exceed 5 minutes. I appeal to all the speakers that they strictly adhere to the speaking time, as also decided by the Commission, chairs of regional groups will be allotted the speaking time of seven minutes max. The Pledges4Action would also take place during our general debates. If you’re making a pledge, please read out your pledge or the end of your statement within the 5 minutes of speaking. Group 77 and China: In Vienna, the rates of commitment continue to work to address and counter the world drug problem. The group would like to express its appreciation for the commendable efforts of the chairperson and the secretariat for the preparation and organisation of the session. The group of 77 and China now welcomes the convening of the high level segment of the commission and expresses its support for the high level declaration of the CND and on the 2024 midterm review, following the 2019 ministerial declaration agreed by the member states. The group views this as a positive step forward. It is important for our joint commitment to address and counter the world drug problems, the group would like to express its appreciation for the work carried out in the negotiation process. The group also take a positive note of all initiatives and effects of its member states which contribute to the world to eh commission, in addressing the world drug problem is a common and shared responsibility that should be undertaken in a multilateral setting through effective concrete and increase subregional, regional and international cooperation based on integrated multidisciplinary mutually reinforcing balanced, scientific evidence base and comprehensive approach with a view to promoting group stresses the importance of international cooperation and has companies capacity building initiatives, programmes and activities, provision of equipment and technology and technical assistance, particularly for developing countries in an open, transparent and equitable way to allow them to have sufficient resources to address encountered the world drug problem. The group remains strongly convinced that the upholding alternative including supporting an effecting UN development system and avoiding creating and entering unilateral coercive measures and actions on the developing countries in accordance with international law and the charter of the UN is essential to proof solidarity international cooperating frame and the international cooperation framework and for the sustained stabilities to address and counter the world drug problem (….) the 1972 protocol, the Convention on psychotropic substances of 1971. The United Nations Convention against illicit trafficking of drugs and psychotropic substances of 1988 and other relevant international instruments constitute the cornerstone of the international drug control system. The group reaffirms its committed to ensuring that all aspect of the main reduction and related measures like reduction and related measures and international cooperation are addressed in full conformity with the purposes and principles of the charter of UN international law and Universal Declaration of Human Rights with full respect for the sovereignty and territorial integrity of states the principle of non-intervention internal affairs of other states or human rights, fundamental freedoms in the current dignity of all individuals and the principles of equal human rights and mutual respect among states. The group reiterates the efforts to achieve the sustainable development goals and effectively address a worldwide problem…and mutually reinforcing The growth nodes with great concern the persistent disparity some progress made in ensuring the access availability and affordability of controlled substances for medical and scientific purposes, particularly for pain relief and palliative care. The group urges all member states to take concrete actions to ensure access availability, availability and affordability of controlled substances for medical and scientific purposes and remove any imposed barriers. The group acknowledges that drug use disorders face challenges that should be addressed effectively through treatment, healthcare, rehabilitation and recovery. The group recalls the UN Declaration on the Rights of Indigenous Peoples and recognises the importance The group underscores the significance of the United Nations Declaration on the Rights of Indigenous Peoples, emphasising the need to support sustainable livelihoods for indigenous peoples and local communities affected by the illicit crop cultivation and drug trafficking. It highlights the importance of promoting domestic economic alternatives through long-term, inclusive, and sustainable development programs aimed particularly at those communities and regions vulnerable to illicit crop cultivation and drug-related activities in both urban and rural settings…..The group points out the detrimental effects of transnational criminal organisations on public security and societal well-being, advocating for a comprehensive approach to combat the spread of these activities. Concerns about the growing threats posed by synthetic drugs to the illicit drug market are raised, with a call for member states to prioritise addressing this challenge. The adverse environmental impacts and the broader consequences of drug-related activities are acknowledged, with a stress on the necessity of addressing these issues and their root causes. The group calls for ongoing support from the UNODC to assist member states in adopting integrated, multidisciplinary and evidence-based strategies to counter the WDP in line international drug control conventions and other intentional drug policy commitments. acknowledges the persistent, new, and evolving challenges in drug control, advocating for ambitious, effective, and possibly innovative actions within the framework of the international drug control conventions. Lastly, the group notes the conventions’ flexibility, allowing states to tailor national drug policies to their specific needs and priorities, reaffirming the principle of common and shared responsibility and adherence to international law. The group emphasises the need to integrate gender and age perspectives into drug-related policies and programs, focusing on the well-being and safety of individuals, families, communities, and society, with special attention to women, children, and youth. This includes promoting health and access to treatment. The group expresses concern over the lack of equitable geographical representation and the underrepresentation of developing countries in the UNODC…. on implementing this principle, the progress made, and suggestions for improving member state representation in the UNODC Secretariat. Furthermore, the group, including G77 and China, calls on the international community, especially developed countries, to provide necessary support to enhance efforts to address and counter the world drug problem, underscoring the importance of global cooperation and support. Group of African States: I have the honour to deliver on behalf of the African group. We align ourselves with the G77 and China statements. Warm congratulations to his excellency for election as chair. We thank the secretariat for excellent preparations for this session as he is tasked with conducting a stock taking review on progress made on 2019 MD and thank you for tireless efforts and leaderships and work to reach consensus and uphold Vienna spirit. We express support for innovative pledges for action to ensure impactful efforts to address WDP. Commend Ghada Waly for able leadership and guiding our efforts to address WDP and strategic vision for Africa 2030. We urge UNODC to provide sufficient financial and technical support for African countries to ensure successful implementation of SDG mandate and agenda 2030. Addressing and countering WDP is common and shared responsibility and we reiterate our commitment to the 2009 Political Declaration, 2014 Ministerial Declaration, 2016 UNGASS Outcome Document, and 2019 Ministerial Declaration. We note appreciation of efforts of the African Union to craft collaborative submissions to mid-term review. Welcome African Union plan of action on drug control. We note grave concerns on disparities of accessibility and affordability of controlled substances for pain and palliative care. We urge the UNODC, member states and the private sector, particularly the pharmaceutical industry, to remove barriers in this regard. We are concerned about linkages between organised crime such as terrorism, financial crime, and drug trafficking, and call for collaboration with law enforcement agencies. We take note of the decision to delete cannabis and cannabis resin from schedule 4 and place it in schedule 1 while we note that states have domestic control in this regard. We express concern about the threat of synthetic drugs and urge states to tackle this challenge. We note with concern the increasing non-medical use of medical opioids and note we should consider placing these under control while ensuring access for medical and scientific purposes. We note the increasing use of the dark net and increased trafficking of precursors. We affirm the role of CND as principle decision making body on drugs and treaty mandated roles of INCB and WHO. We commend ED for ensuring geo representation and gender balance in recruitment policy of UNODC. Resolve to review 2029 progress made on commitments and ensure efforts to reach goals in period 2024-2029 Group of Asia-Pacific States: Chair, ED, excellencies, delegates,etc. On behalf of the Asia Pacific group we thank and congratulate the chair. We congratulate other elected members. Extend full support to ED of UNODC and DG of UN Office in Vienna. We work together on collective efforts to tackle drug use. We affirm that UNODC is the principal entity to tackle drug related issues and the CND is the principal fora. We acknowledge with appreciation the adoption of high level declaration and note the work to prepare for this session. We affirm our belief that the world drug problem is a multifaceted challenge with a need for a multidisciplinary approach within the principle of common and shared responsibility. We recognize efforts of national authorities in law enforcement, criminal justice, health and education and recognize the provision of technical assistance for these authorities where necessary. We recognize efforts to counter the world drug problem through demand reduction, supply reduction, and through international collaboration through principles of UN charter and with respect for international law and sovereignty of states as well as principles of equal rights and respect among states. We recognize that efforts to counter the world drug problem and to achieve the 2030 Sustainable Development Goals are complementary and mutually reinforcing. We recognize the key drug control conventions as the cornerstone of the international drug control system, as well as the 2009 Political Declaration, 2014 Ministerial Declaration, 2016 UNGASS Outcome Document, and 2019 Ministerial Declaration. Group fully supports efforts to counter illicit cultivation, production, trafficking and drug supply and demand, as well as precursor chemicals. We note the need to strengthen interregional and international collaboration and exchange of information where appropriate. In the context of this mid term review we reflect on the achievements and challenges in these commitments from the 2019 Ministerial Declaration. We express with concern the threat of spread of amphetamine type stimulants, especially methamphetamine and new psychoactive substances and non scheduled precursors. We ensure we will work towards comprehensive access to treatment programs in compliance with control conventions. Group of Latin American Countries and the Caribbean: GRULAC recognises that despite progress, the WDP continues to pose challenges to health, citizen safety and the wellbeing of our people and countries of the region. The progress in raising awareness on the impact of drug activities on the environment is positive. The WDP has worsened internationally. We must redouble our efforts to find joint solutions to tackle this challenge. Our region is affected by the rapid transformation and expansion of these challenges and the links between illicit drugs and arms trafficking. Undermines the forces of law and order. Drug trafficking and rise of violence, have a negative impact on the well-being of our people. Urgent need to adopt ambitious, innovative, preventive, multidisciplinary, balanced policies in addressing WDP respecting national legislation and on the principle of common and shared responsibility. In keeping with the principles in the Treaties and all relevant instruments that are the keystone of the UN drug control system, and in lights of the UN Charter, international law, and the Universal Declaration of Human Rights, we recognise the importance of the critical reviews with scientific basis organised by WHO in contributing to implementing the Treaty-based system. We acknowledge the measures by countries to promote such reviews of substances, products and plants. More integrated responses are needed to tackle the economies linked to illicit drugs and related crimes. Deplore impact on the environment and the damage caused to remote communities and Indigenous peoples. We understand the need to strengthen all efforts towards promoting viable alternatives among affected communities. Particularly those risked being affected by illicit crop cultivation and production of drugs and other illicit activities related to drugs in rural and urban areas, including by developing alternative sustainable and inclusive alternative developments programmes. Indigenous peoples have a right to their traditional medicines, including through their medicinal plants, in line with the UN Declaration on the Rights of Indigenous Peoples. GRULAC highlights the importance of international cooperation, capacity strengthening programmes and activities, and technical assistance, equipment, technology, etc. In particular for developing countries so that states have sufficient resources to tackle and curb the world drug problem in a comprehensive and sustainable manner. Concern for trafficking of NPS and synthetic drugs that lead to irreversible harm among the youngest and underscore the need to strengthen solutions. Commend the Chair for the Pledge4Action initiative to progress commitments in the 2019 Ministerial Declaration. GRULAC is committed to examining, at the CND in 2029, the progress achieved in complying with all international commitments, and review our policy for the health, safety and wellbeing of our peoples. Congratulations on the Outcome Document. European Union: It is my honour to speak on behalf of the European Union and its Member States. The following countries also align themselves with this statement: North Macedonia, Montenegro, Serbia, Albania, Ukraine, Republic of Moldova, Bosnia and Herzegovina, Georgia, Iceland, Liechtenstein, Norway, and San Marino. As we gather today, we are witnessing conflict and violence in many parts of the world. The EU and its Member States call for the full respect for the UN Charter and International Law and International Humanitarian Law, whether in relation to Russia’s war of aggression against Ukraine, or the ongoing conflicts in the Middle East, Sudan, Ethiopia, DRC and elsewhere. The EU and its Member States strongly and unequivocally oppose the use of the death penalty under all circumstances, including for drug-related offences. The challenges posed by the world drug situation are increasing. Recent data on drug-related deaths, as well as on the production and trafficking of drugs and their consequences cause great concern. The latest World Drug Report tells us that over 128.000 people died in the world in 2019 due to drug use disorders. Seizures of drugs, in particular cocaine, keep on growing, having gone up in the EU by more than 400% over ten years. In particular, drug production and trafficking are at an all-time high and criminal groups and networks are becoming a bigger threat. At the same time, the sharp rise of new psychoactive substances comes about with new health challenges and the production of drugs damages our environment. We deeply regret the continuous unequal impact of the world drug situation on the most vulnerable individuals, families and populations. Still today, access to and availability of controlled substances for medical and scientific purposes remains extremely low in many parts of the world, resulting in immense suffering for individuals, families and communities. The European Union and its Member States are convinced that the situation can be tackled in an effective and sustainable manner only through an evidence-based, integrated, balanced and multidisciplinary approach that upholds human rights. The three international drug control conventions, with the purposes and principles of the Charter of the United Nations, international law, and in particular international human rights law, should remain cornerstones of international drug policy. We must continue and accelerate the implementation of all drug policy commitments, and in particular the commitments agreed upon in the UNGASS 2016 outcome document. Without a doubt, our common efforts should contribute to the achievement of the Sustainable Development Goals set out for 2030. The EU Drugs Strategy and related Action Plan 2021-2025 set out the EU policy in this field. The European Commission will evaluate the implementation of our policies and actions in 2024 to guide the future EU drugs policy. In response to the increasing challenges linked to organised crime and drug trafficking, the European Commission recently published an EU Roadmap to fight drug trafficking and organised crime. Together with EU Member States, the Commission is undertaking several priority actions, such as the launch of a European Ports Alliance, ongoing efforts with all stakeholders to protect ports from criminal infiltration, more targeted actions against high-risk criminal networks, or increased efforts of crime prevention, including preventing the recruitment of young people into organised crime. Furthermore, drug use is first and foremost a health issue. There is no single cause to drug use nor is there a single solution to address drug use disorders. Following the scientific evidence, the EU and its Member States are implementing policies encompassing activities in the areas of prevention, early detection and intervention, risk and harm reduction, treatment, rehabilitation, social integration and recovery. This includes the implementation of innovative services, such as online treatment, or developing community-based programmes and mobile services in order to reach the most vulnerable populations. Should we therefore be complacent? No. Drug health policies must constantly improve and respond to new health challenges and thus, by definition, be innovative. Firstly, we have to protect the most vulnerable. As stated by Executive Director Waly in the latest UNODC report: ‘It is the vulnerable, the poor and the excluded who pay the highest price’. Stigmatisation of people for their drug use is unacceptable and counterproductive and should therefore be tackled and eliminated. Secondly, as policy makers, we must listen to civil society and people with lived experiences. Thirdly, gender equality. Access to healthcare for women is more limited than for men and the stigma on women who use drugs is ever so hard, especially when they have children. At the same time, women are convicted proportionally more than men for drug-related offences. Finally, data. The European Union and its Member States underscore the essential role of collecting data, monitoring and scientific research. As from July this year, the current European Monitoring Centre for Drugs and Drug Addiction – EMCDDA – will become the European Drugs Agency (EUDA) with a reinforced mandate. We will improve our capacity to react to both current and future drug challenges. With a view to enhancing the implementation of all international drug policy commitments, and in addressing the challenges that the range of drugs and drugs markets are expanding and diversifying, I therefore pledge for the European Union to increase its preparedness and capacity to react to future developments by empowering its European Union Drug Agency to carry out proactive threat assessments and to develop a rapid European drug alert system complementary to our already existing Early Warning System that will contribute to safeguarding public health and security. Mr. Chair, The challenges are many, and only jointly we can face them in a sustainable manner. Thank you Colombia (video message): The international drug control regime, with its gravity center in Vienna, has failed. The latest World Drug Report from the United Nations Office on Drugs and Crime demonstrates this. Illicit drugs are readily available to all, while controlled medicines do not reach the patients who need them most. In other words, this global, anachronistic, and indifferent system has failed to destroy the illicit substance market or promote the legitimate medicine market. It insists on pitting the state against the market and thus endangers our countries and our people. This war on drugs has failed primarily due to: The increase in fentanyl consumption in the United States, resulting in over 100,000 deaths per year. One million murders in Latin America, making it the most violent region in the world due to drug criminalization. Tens of millions of people imprisoned throughout the drug trafficking chain, including peasant farmers who produce coca leaves. The destruction of democracy due to corruption and the armed takeover of territories by criminal organizations in Latin America. The health of our societies is at stake. The risk posed by the use and abuse of illicit drugs, both natural and synthetic, can only be mitigated through a harm reduction policy that prioritizes a public health approach. Colombia calls on the membership of the Commission on Narcotic Drugs to place the right to health at the center of its debates. The health of our democracies is at stake. Drug mafias, created by prohibition and criminalization, transfer their money northward to benefit the financial system controlled by major capital, leaving violence and destruction in our global South. They do not want strong institutions to combat them, nor empowered and educated populations with their basic needs met. They need them weak to corrupt and co-govern. They need them poor and subservient to cultivate, produce, and traffic. Colombia urges the Commission on Narcotic Drugs to recognize that arms trafficking, money laundering, and corruption are part of the engine of the global phenomenon of illicit drugs. Colombia implemented all the wrong formulas imposed on us from outside for a war on drugs. We bore the dead, entrusted soldiers and police with an impossible mission, wasted money from our budget, turned our peasant, indigenous, and Afro communities into enemies, violated rights massively and systematically, contributed to destroying our ecosystems, and sacrificed our development for a war others wanted. What the world calls the global drug problem reflects above all the loneliness of millions of people in developed societies today addicted to drug consumption and the lack of opportunities for communities within legitimate economies. There is no drug problem, but rather one of development and existence. The denialist spirit prevailing in the face of the multilateral drug system’s shipwreck is forcing countries to respond within the framework of flexible interpretations of conventions. Colombia is doing this on two levels. Internally, our national drug policy places the fundamental rights of Colombians at the heart of our action. Coca leaves are part of our history, and they are not the problem you have in Vienna. We will provide oxygen to the peasant farmers who cultivate coca leaves and suffocate those who profit from trafficking cocaine. This drug policy is part of the quest for total peace within and beyond borders, peace with local communities, and peace with nature, the right to life above all. Internationally, Colombia has called for a reassessment of the global drug situation. We will start in our region of Latin America and the Caribbean and want to bring this debate to the rest of the world. A former president of the United States said, and I quote, “with the United Nations when possible, without the United Nations when necessary,” end quote. We believe that everything should be done with the United Nations, but not with a United Nations that is deaf, blind, and silent. <a href="https://www.facebook.com/watch/?v=1549653769147031">Video message also available here.</a> Colombia: Making this statement on behalf of a group of countries (Albania, Andorra, Armenia, Australia, Austria, Belgium, Bolivia, Bosnia and Herzegovina, Brazil, Bulgaria, Canada, Croatia, Colombia, Costa Rica, Cyprus, Czechia, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Greece, Guatemala, Honduras, Hungary, Iceland, Ireland, Italy, Kiribati, Latvia, Liechtenstein, Lithuania, Luxembourg, Malta, Mexico, Moldova, Montenegro, Netherlands, New Zealand, North Macedonia, Norway, Panama, Poland, Portugal, Republic of Korea, Romania, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Timor Leste, Ukraine, United Kingdom, United States, Uruguay). This group of member states convey the following messages at the opening of the HLS of the 2024 midterm review. We are gathering at a time when the international community needs urgent action against drug challenges that endanger the health, human rights, wellbeing and security of peoples. Then demand for and supply of drugs have reached unprecedented levels with illicit trafficking and manufacturing leading to violence, causing people to fear and lack of protections and lack of trust in their government’s capacity to protect them. At the same time, despite their indispensability, millions of people suffer because of inadequate access to and availability of controlled medicines due to affordability, and other system obstacles. In many communities, illicit drugs are available, controlled drugs aren’t. This leads us to conclude the international drug control system as currently applied needs rethinking based on concrete evidence to make progress together. Drug related organised crime thrives worldwide, disrupts governments, diminishes democratic institutions, incentivises corruption, leverages the internet, undermines rule of law. Proceeds of crime exacerbate an array of illegal economies including human trafficking and crimes against the environment. Disrupt societies, harms the functioning of states, economic costs, hindering the achievement of the SGDs. Patterns are changing rapidly. Synthetic drugs are expanding at an alarming pace. Global threat against young people. Extreme lethality and ease of traffic. Unprecedented overdose deaths and poisonings. Ultimately, human rights issues directly impact the health and wellbeing of our people. The number of people with drug use disorders: 39.5 million. 45% increase in the last decade. Evidence shows these disorders are multifactorial health conditions that need rights based inclusive harm reduction healthcare, social protection, rehabilitation, and protection within the context of health systems that provide non-stigmatising approaches. Those in need of treatment of services face significant obstacles. Importance of harm reduction approaches grounded in human rights and gender perspective. To contribute to the realisation of gender equality and enjoyment of all human rights. Putting people first is part of our broader efforts, prioritising public health, developing prevention, eliminating stigma associated with drug use disorders, and ensuring access to availability of controlled substances for medical purposes. Our global policy should be to treat people with dignity and uphold their human rights. It should increase viable economic alternatives, including through alternative developments, including economic solutions for people of african descent, indigenous people, homeless population, youth, women…at risk for drug related activities. We regret the impact of drug use and trafficking on marginalised people. International guidelines on human rights drug policy is important. Welcome report by OHCHR as a tool for further discussion. And the presence of representatives from UN bodies here in Vienna. Important step to avoid working in silos. Enhance exchanges between Vienna, Geneva an dNew York. We commend civil society’s role in developing effective policies. We appeal for global solidarity and cooperation to relieve the harms of this worldwide phenomenon. If we want to impact households around the globe, transformation of our vision on drug policy. Realistic evidence based assessment and pragmatic response. We are committed to collectively reviewing and strengthening the international drug control system, ensuring that implementation challenges are addressed and that our focus remains on protecting the rights and well-being of humanity. In this critical and decisive moment, let’s act for the sake of future generations. Despite the challenging social and political climate we currently navigate, let’s come together for the betterment of our people.Starting here and now. Now allow me to voice the pledges and commitment on behalf of Colombia: 1) Design and implement an international harm reduction network so that this approach becomes a lynchpin of global drug policy. 2) Adopt a pragmatic approach that protects rights. Bolivia (Plurinational State of): Natural coca leaf is like an emblem that protects the identity of the ancestral Andean Masonic people’s brothers and sisters. In 1961, the United Nations organisation took the political decision without scientific basis that the coca leaf is the same as cocaine. Classifying the natural coca leaf for over six decades as a drug was an error and a scam. In order to monitor analyse the industrialization of the natural coca leaves for energy drinks, and pharmaceuticals without in any way stamping out the use of coca leaf for drugs for increased crime, my man for murder and for dirty profits for the transboundary industrial peoples living in the territories of Bolivia Peru, Ecuador and Colombia. The natural coca leaves. There is a profound social purpose conciliatory in nature, providing equity and respect among peoples. Classifying for over 6 decades as a drug was an error and a scam, in order to monopolise the industrialization for energy drinks and pharmaceuticals without stamping out the use of coca leaves for crimes… murder and dirty profits. For us, living in the territories in Bolivia, Peru, Ecuador and Colombia, the coca leaf has a profound purpose – equity, respect among peoples. This proof, that the coca leaf is not a drug, is gaining ground in our collective word . The first step was decriminalising the chewing of coca leaves in our national territories. It cannot be considered a drug, for millennia, it has been used to support the survival of our civilization, an excellent therapeutic and nutritional guide and spiritual tool. It is a perfect genetic masterpiece of mother earth – A balanced combination of proteins, amino acids, minerals, oils, antioxidants, and vitamins supports the digestive, immune, lymphatic, nervous, and glandular systems. Recognizing the importance of respecting the rights of ancestral peoples in drug control policy, the Permanent Forum on Indigenous Issues has recommended such respect, a stance reaffirmed by recent resolutions of the General Assembly and the Human Rights Council of the United Nations. These resolutions emphasise the right of indigenous peoples to participate in decision-making processes affecting their cultural integrity. An essential step toward aligning the drug control system with the rights of indigenous peoples is re-evaluating the current classification of coca leaves as a drug under Schedule I of the 1961 convention. Bolivia’s request for this review has been submitted and is currently being considered by the WHO’s expert committee. We have advocated for the WHO to incorporate a traditional medicine perspective in this critical review process. The review of the coca leaf presents a prime opportunity for the World Health Organization to engage with indigenous communities and bridge the gap between academic and natural medicine. In our arguments for the critical review, we have reiterated our commitment to ensuring that the drug control system—based on the 1961, 1971, and 1988 treaties, which govern drug control and prohibit the cultivation and use of coca leaves for illicit production—respects and integrates the legitimate uses and cultural significance of the coca leaf.Our request was submitted and is being reviewed by the WHOs relevant committee. This is an excellent opportunity to engage in dialogue with indigenous peoples and forge bridges between academic and natural medicine. We have reaffirmed our commitment to the drug controls system – based on the three conventions that control illicit production of coca leaf. In turn, in the reservation under the single conventions, we have ratified that Bolivia will take necessary steps to … we restated our strategic commitments in our national counter-drugs policy with results we shall present during a side event later today. Freeing the coca leaf will generate great health benefits and opportunities for marketing and industrialization, for humankind. Spain (video message): Distinguished chair, delegates, ladies and gentlemen, warm greetings. As the Minister of Health of the Spanish government, I am honoured to address the Commission on Narcotic Drugs, a pivotal multilateral forum of which Spain, as a member since the First Vienna session, fully aligns with the declaration delivered by the European Union. We gather here to engage in the midterm review of the 2019 ministerial declaration. I wish to emphasise the importance of a shared roadmap to evaluate the progress we have achieved and to outline future steps towards fulfilling our commitments. In Spain, our national addiction strategy is spearheaded by the government’s delegation for the National Drug Plan. This strategy is the result of a comprehensive consensus among public governance, the scientific community, civil society, and both the public and private sectors. Through our collaborative efforts, we have been able to establish priorities and design tailored responses within our national drug plan, demonstrating our commitment to addressing addiction comprehensively. This is a balanced approach and actions are based on full respect for human rights and are aimed at creating better awareness, safety and health of all people – free from discrimination and stigmatisation. We place importance on the most vulnerable. These findings underscore the critical need to address drug-related disorders, which often coexist with other mental health issues. This represents a particularly vulnerable group within our population, including young individuals. Furthermore, international cooperation is essential, based on shared responsibility and commitments outlined in international treaties and laws. Our collaborative efforts extend across various regions, with a particular focus on the Americas. We are committed to strengthening partnerships between the European Union and the Community of Latin American and Caribbean States (CELAC), through a series of programs funded by the European Union. On a multilateral level, we provide both technical and financial support to various projects. Additionally, we participate in the coalition against synthetic drugs led by the United States, underscoring our dedication to tackling the global challenge of drug-related disorders through international collaboration and support.A number of programs are funded by the EU and we are providing technical and financial support to a number of initiatives, worldwide. The Ministry of Health emphasises the necessity for decisions to be informed by reliable data and scientific evidence, particularly in the realms of prevention and treatment of drug-related issues. Highlighting the importance of political support and adequate resources for these activities, Spain plans to address this topic further during a side event next Monday. In support of the “Pledge4Action” initiative launched by the chair of the Commission on Narcotic Drugs, Spain commits to enhancing the implementation of international drug policy commitments and tackling health service and drug treatment challenges. This commitment includes actively promoting the development of treatments based on scientific evidence, adhering to international norms and standards, and focusing cooperation efforts on countries in the Latin American region. Spain will continue its collaboration with the United Nations Office on Drugs and Crime, particularly in prevention, treatment, and rehabilitation, by providing institutional and technical support, and actively contributing financial support through to 2024, with intentions to sustain funding into 2025. As the Minister of Health, I extend our best wishes for success in our ongoing and future endeavours. Kazakhstan: Dear colleagues, it is an honour to participate in this commission’s review of our international policy commitments. Kazakhstan, as a signatory to all three major narcotics conventions, steadfastly adheres to the principles of the UN Charter in addressing global challenges. Nationally, our approach transcends enforcement, emphasising respect for human dignity, which aligns with our President’s guidance and the essence of the 2019 ministerial declaration. Last year, Kazakhstan introduced a comprehensive plan to counter drug trafficking, developed in close collaboration with local experts, the UNODC, and other international bodies. This plan is grounded in compassion and understanding, while also updating law enforcement techniques. Its implementation has already led to significant achievements, including the arrest of numerous traffickers and the dismantling of 81 illicit labs. This strategy exemplifies our commitment to both humane principles and effective action in the battle against drug-related issues. Trafficking transcends national borders and personal boundaries. International collaboration has a critical role in addressing this challenge. We must address root causes and tackle impacts on communities. Our priorities in combating trafficking in central asia are: monitoring the infamous northern route, confiscation of synthetic drugs have increased more than 10 fold that poses a major risk to our national security. Therefore we will convene with UNODC next month and join efforts to address these synthetic drug threats. Addressing the situation in Afghanistan, it’s important to note that international isolation only worsens the country’s humanitarian and socioeconomic crisis, potentially leading Afghan farmers to return to cultivation practices.In our efforts to address security issues, including drug trafficking, we are actively pursuing meaningful, multilateral dialogue with the de facto authorities in Kabul. In this vein, we propose the establishment of the United Nations Centre for Sustainable Development for Central Asia and Afghanistan, based in Almaty. This centre aims to embody the “One UN” approach and enhance collaboration among international organisations. We invite all stakeholders to join us in this critical initiative, embodying the principles of multilateralism and good faith. Given the global impact of drug trafficking, a perilous social issue affecting states and regions worldwide, our collective response must be rooted in compassion and expertise. Together, we can forge a brighter future, aspiring for a world where every child can grow up in an environment free from the scourge of drugs. In addressing the challenges of drug treatment, I declare that Kazakhstan will build specialised health and rehabilitation facilities. I am honoured to be joined by the whole family of those fighting against illicit drug trafficking. Honduras: The government of Honduras restates our commitment to the three drug control treaties, political declaration, UNGASS 2016 outcome document to combat world drug problem, and Ministerial Declaration of 2019. We recognize the need to cooperate to combat drugs. At this time it is clear that we need joint efforts and a resounding response and equally fundamental that we address other crucial issues such as poverty, health, education, based on respect for human rights. Need to ensure we can tackle multifaceted challenges effectively. Purpose of our democratic and socialist government is to forge an equitable country, however the world drug problem poses significant obstacles and without cooperation progress is unlikely. We are here to take stock and learn. Recognize the link between production and consumption and need to tackle the increase in production. Need to promote social wellbeing and protection of our people. We face multiple challenges as a country of transit but we are fully committed to this global challenge which has had severe impact on our region, compelling families to leave their homes. We are committed to tackling challenges of organised crime over the past dark years in Honduras where trafficking invaded the state to unprecedented degree. Our country has made headlines due to the conspiracy of the former president to traffic drugs into the United States. This was forged by funds from the state, leading to electoral fraud and tens of thousands of deaths among the civilian population. This was initially stemming from a coup in 2009 overthrowing the President. In this time we shifted from being a country of transit to a producer country and we are committed to making Honduras a safe country to prevent and combat trafficking once again. We have announced flagship interventions and have achieved a reduction of 11 points in homicide rate, to 41 per 100,000 people. We have announced a state of partial emergency in conflict areas under cartel control. We have eradicated 4.5 million coca plants, 4.7 tonnes of cocaine, 11.5 tonnes of weed, as well as 11,000 doses of fentanyl, highlighting the need to tackle the increase in synthetic drugs. We request the UN to establish a mechanism to tackle corruption. To this end the General Assembly adopted a resolution mandating Secretary General Antonio Guterres to implement this mechanism and continue to make progress to this end. We see multilateralism as a key component to tackling the scourge of drugs. We hope to build a more equitable country and equally tackle difficulties caused by shortage of controlled substances for medical use. We urge protection of public health for all. My country states its commitment to reduce trafficking in drugs, precursors and money laundering to mitigate impact on public health and negative impact of drug use. We hope to continue to contribute to regional efforts to combat drug use and combating transnational crime. Albania: The World Drug Problem poses a significant threat to countries and societies, impacting social and economic conditions and threatening the rule of law. The increasing complexity of the drug market exposes users to a wider array of psychoactive substances, which can lead to severe health risks, including death and poisonings. Notably, many drugs are now leading causes of death among middle-aged citizens, signifying the complex challenges spreading throughout society and placing a massive toll on public health and the criminal justice system. The urgency of addressing these issues is underscored by the support of the United States, with Secretary Blinken expressing concern and urging global action to combat the synthetic drug threat—a commitment we share. Addressing this requires investments in treatment facilities and a robust criminal framework. We are actively engaged in combating drug trafficking, focusing on collaboration among authorities and cross-border initiatives. However, challenges remain in detecting emerging threats and providing adequate treatment and support for recovery. We continue our efforts to harmonise our legislation with EU codes, aiming to protect security, health, and prosperity, particularly among the youth. Efforts to dismantle drug distribution networks in schools have led to prosecutions related to cannabis cultivation. We are aligning our efforts with international efforts and pledge to establish by 2025 a national early warning system to continuously update the list of drugs posing harm to public health, and by 2026, a national drug observatory to analyse and process drug-related data to reduce both drug demand and supply. These initiatives will be supported through close collaboration with international partners, such as UNODC, INCB, EMCDDA, and the global coalition to address synthetic drug threats. A shared responsibility is essential to ensure prosperity for all. South Africa: We align with the statements of the Africa Group and G77 and support the initiative led by the US to form a global coalition against synthetic drug threats. We express our objection to the ongoing violence and the disregard for international law in Gaza, emphasising the necessity for an immediate ceasefire, access to humanitarian aid, and life-saving medicine. The enduring solution lies in the establishment of a Palestinian state alongside Israel, based on the 1977 borders and in accordance with relevant UN resolutions and international law. Reflecting on progress since the 2019 Ministerial Declaration, South Africa reiterates its commitment to the three drug conventions, complemented by our national drug master plan aimed at addressing and countering the World Drug Problem (WDP). In our efforts, we hosted our third national summit on substance abuse and international trafficking to reduce the demand, supply, and harm caused by the use, misuse, and abuse of drugs. The persistent and emerging challenges underscore the need for international collaboration, particularly on issues affecting access to controlled substances for medical use. The prevention of access to medicine contradicts international standards, and the challenge of affordability must be addressed. We welcome efforts by the African Union to expand local manufacturing of these essential commodities. We also take this opportunity to announce our nomination of Professor Zingala (?) for President of the International Narcotics Control Board (INCB) and seek support for her candidacy. Recognizing the gap in drug treatment and prevention efforts, South Africa pledges to implement evidence-based strategies for treatment and prevention within the next 12 months, underscoring our commitment to addressing this challenge effectively.. Chair: It is my pleasure to first give the floor to two representatives, Pauline Laurie and Elias Hague who would address the meeting on behalf of the Youth Forum held on 12th and 13th March 2024. Youth Forum:We stand before you today as 35 youths from 27 countries, noting with great concern the issue of substance use and the grave consequences which it brings. Substance use is not only detrimental to individual health and well-being, but it also worsens many aspects of our society. Our commitment to substance use prevention can ensure better health outcomes, reduced poverty rates and social stability. We bring forth the significance of addressing the root causes and vulnerabilities behind substance use to effectively implement sustainable solutions. We understand that resources are scarce, and emphasize the pivotal role that evidence-based prevention can play to ensure a maximal effective result, and foster a foundation for long-term social well-being and individual flourishing. In the context of substance use prevention, an approach based on evidence can and will, give us guidance and support to achieve our goal. By prioritizing early prevention initiatives that foster healthy development, global productivity and prosperity can be increased to ensure sustainable creation of healthier lifestyles. In this process, no one should be left behind. Witnessing the detrimental impact of substance use on our peers has reminded us of the urgent need for action. Ensuring youth engagement in evidence-based substance use prevention can catalyse positive change, injecting fresh perspectives into the veins of our society. By providing youths with various leadership roles, skills development and peer support networks through youth-led organisations, peer-to-peer education, mentorship, and social media, we can pave the way for a better tomorrow. Youth can be a powerful source of empathy and support for the community. Yet, without your support, this is not enough. So we call on you, decision-makers, to put yourselves into our shoes, and when signing each drug-related policy, picture how it feels to be young and see our futures fall to conditions and situations that we cannot control. We urge Member States to increase youth engagement in science-based prevention interventions. It is your responsibility to reduce the power dynamics between young people and adults, ensuring that we feel empowered to act as your equal counterparts. To do so, we must be provided with a socially relevant platform – a voice of our own, through which we can finally make ourselves be heard. Our call is for Member States to help us in: building the foundations for structured and systematic youth-led action; providing infrastructure, opportunities and conditions to equally empower youth to make informed and consent-based decisions; and implementing prevention efforts regardless of abilities, languages, and cultural differences. We urge decision-makers to closely collaborate with local NGOs, social groups, schools and universities to provide substantial support, such as but not limited to, funding, knowledge and skills. Our message and call to action is to prioritise drug use prevention, especially among youths, and to invest in evidence-based, early, and youth-centred prevention strategies. By working together and empowering young people to care for health and well-being, we can create a brighter and healthier future for all. Passion moves hearts, support moves hands. We have the passion, the heart and the hands: give us the support and change will happen. UNODC-WHO Informal Scientific Network: Good afternoon, everyone. I serve as the director of the National Institute on Drug Abuse at the NIH (??). Today, I represent the UNODC’s informal scientific network. I want to commend the youth for their passionate and compelling call for the prevention of addiction and substance use disorders, which is precisely the focus of my statement today. Adolescence is a critical time of growth and transitions, often marked by the risk of experimenting with substances. Early substance use not only increases the likelihood of developing substance use disorders but can also disrupt neurodevelopmental and educational achievements, underscoring the crucial need for prevention. Despite the availability of evidence-based prevention interventions, as outlined in the UNODC-WHO International Standards for the Prevention of Drug Use, their implementation remains woefully inadequate. We need more resources to sustain implementation. Mental health conditions are key to look at – screening for comorbidities in adolescence can prevent substance use disorders. The factors that heighten the risk for substance use and substance use disorders include untreated mental health conditions. Screening adolescents for comorbid mental health conditions, so they can receive early treatment, can help in preventing substance use disorders and enhance outcomes for those already affected. Evidence-based treatment interventions, aligned with the UNODC-WHO International Standards for the Treatment of Drug Use Disorders, are readily available. These treatments range from behavioural and psychosocial interventions to pharmacological treatments if necessary, including the treatment of comorbid mental health disorders. There’s a critical need for more investment in adolescent-friendly and safe treatment and support services that are non-discriminatory, punitive-free, equitable, and accessible. Additionally, expanding the qualified prevention and treatment workforce is essential. Digital interventions for prevention and treatment hold promise for reaching more adolescents but must be closely monitored to ensure their safety and effectiveness. We need to increase our understanding on adolescent substance use. Quoting our own resolution, children are our most precious asses and we must protect them. Governments must put efforts into putting theories in practice.In addition to the statement of the Informal Scientific Network, I will read the statement of the UNODC Consultation of scientists and community leaders on the progress made in meeting the global commitments to end AIDS as a public health threat by 2030 and eliminate hepatitis C among people who use drugs. People who use drugs are disproportionately impacted by HIV and viral hepatitis, with hepatitis C being the number one cause of drug-related deaths globally. The societal and structural reasons for this are well documented: The criminalization and over-policing of people who use drugs prevents them from accessing healthcare. Inadequate funding and implementation of harm reduction services increases the risks of overdose, HIV, and viral hepatitis. Stigma and discrimination against people who use drugs – especially for women, young people, Indigenous peoples and people in prison settings – and the denial of their human rights pushes them to the margins of society The failure to involve communities in research, policy formulation, and the design, implementation and evaluation of harm reduction interventions renders programmes less effective Our consultation confirmed that needle and syringe programs, opioid agonist therapy and naloxone for overdose management are essential parts of a person-centred, evidence-based HIV and hepatitis response. In countries that implement these services at scale and have strong records in protecting human rights, HIV and hepatitis C transmission rates among people who inject drugs are significantly reduced, while drug use and other drug-related harms did not increase. We therefore call upon the CND to renew its political commitment to a sustained public health response with and for people who use drugs. To prevent the unacceptable levels of overdose mortality and transmission of HIV and hepatitis we recommend: To act on the evidence and continue to support more data collection, research, innovation, and community leadership. To increase collaboration with the widest possible range of partners and stakeholders, especially those who have historically been excluded. To capitalize on the knowledge and experience of communities of people who use drugs and fund them to design and implement harm reduction programmes. To put our human-rights obligations at the heart of our response This way we will truly be on our way to reduce inequalities, putting people first – leaving no one behind. VNGOC: Mr Chair, distinguished delegates, Excellencies, ladies and gentlemen. Thank you for allowing me to speak today. I am pleased to make this statement on behalf of both the Vienna and New York NGO Committees on Drugs. The past year has been one of the most challenging and demanding in the history of the Vienna NGO Committee on Drugs. In one of the most successful periods of membership growth in recent years, we reached the milestone of 400 members from around the world. In the face of legitimate concerns about the shrinking space for meaningful civil society engagement in post-COVID-19 drug policy processes, we have managed to turn the trend in a positive direction and strengthen the presence of civil society in many areas, including at the UN level. Last year, we entered a joint agreement with the New York NGO Committee on Drugs to work together to ensure the broadest and most inclusive civil society engagement in the 2024 mid-term review. Together, our committees selected 36 civil society speakers for the CND thematic discussions in October and December last year, as well as 11 speakers for the mid-term review. Our committees conducted extensive civil society consultations in the form of a global online survey and four regional consultations. The results fed into a Global Civil Society Report, which was published in February as an official contribution to the mid-term review. I am very pleased to share with you some of the key conclusions from the Global Civil Society Report. The report is the result of constructive contributions from more than 200 NGOs from all regions of the world, representing a wide range of expertise and perspectives on drug-related issues. The report emphasises the importance of meaningful civil society engagement in the formulation and implementation of drug policy at all levels, as well as the challenges and opportunities that civil society faces in this context. Some of the key conclusions from our report are as follows. Firstly, there is a need for capacity building and comprehensive public health training. Secondly, there is a need to invest in evidence-based prevention interventions. Thirdly, access to harm reduction, treatment and recovery services must be improved, as well as access to controlled medicines. Fourth, we must better address the root causes of drug-related problems, such as poverty, structural violence, racism, inequality and lack of access to education and healthcare. Fifth, a shift to health-oriented policies instead of punitive measures is needed. Sixth, greater cooperation between UN bodies is needed to improve coherence between the international drug control system and international human rights obligations and to put equality and non-discrimination at the centre of drug policy. The report is not intended as a consensus document, but rather to highlight the various discussions and perspectives of civil society on drug-related issues. It also outlines some of the limitations we faced during the consultation and drafting process. The report is intended to inform and enrich the dialogue between all stakeholders and contribute to the development of a more effective, balanced and humane drug policy. 44Another key success I must mention is that together with the African Union Commission and UNODC, we supported the launch of the African Civil Society Forum on Drugs, a new regional mechanism for African NGOs to engage with the African Union Commission. A similar mechanism has existed for many years at the European Union level with the regular renewal of the mandate of the European Civil Society Forum on Drugs. Civil society is also very present at the CND again this year, with many side events organised by or with NGOs. Both the Vienna and New York NGO Committees are pleased to be able to bring civil society voices to several of the high-level side events as well as the round-table discussions and the plenary of the mid-term review. We are grateful that the new Outcome Document further commits to involve civil society for the next 5 years of implementation of the 2019 Ministerial Declaration. Finally, I would like to express my sincere gratitude to all the Board members of the Vienna and New York NGO Committees who have worked tirelessly and effectively in the preparations for the High-Level Segment and the 2024 mid-term review. I would also like to thank Portugal, Slovenia, and the US for their financial support in this process, the UNODC Civil Society Unit, the African Union Commission, the European Commission, the African Civil Society Forum on Drugs, the Civil Society Forum on Drugs in the EU, the American Coalition on Drug Policies, and the Intercambios A.C. for supporting our work in gathering civil society inputs for the mid-term review. We also have to thank many others, without whom our work and outcomes would not have been as successful. Last but not least, I would like to thank members of the Vienna and New York NGO Committees, and all civil society organisations, including those who work tirelessly on the ground, even in conflict situations, to improve the lives of their communities. Thank you for your kind attention! UNAIDS: Your Excellency Ambassador Johnson of Ghana and chair of the 67th session of the commission on narcotic drugs, excellencies, UN colleagues, and members of civil society. It’s a great honor to be with you gathered here are leaders whose decisions can save and transform lives, tackle social exclusion, and protect public health for everyone. As leaders, you can deliver on the shared pledge to end AIDS as a public health threat by 2030. If all people can secure the HIV prevention, testing, treatment, and care services that they need to end AIDS, we must ensure that no one is excluded. But today, too often, laws and policies for people who use drugs just exacerbate exclusion. People who use drugs are criminalized in 145 countries and can face the death penalty in 35 countries. The stigma and outright fear that this generates are driving people away from vital health services, driving away the people who most need the services. Only 1% of people who inject drugs have access to the recommended harm reduction services. And what are the consequences? People who use drugs are seven times more likely to be infected with HIV than other adults. And women who use drugs are almost twice as likely to be infected by HIV than men who use drugs. The status quo punishing people who use drugs is causing catastrophic harm. It is further marginalizing the most marginalized members of our society and obstructing the world from achieving our shared goal to end AIDS and protect the health of everyone. But this is not fate. We can change it. And indeed, we know from the evidence how to change it. UNAIDS supports governments and communities to advance approaches to HIV that have been proven to work. In 2012, Estonia was number one for new HIV cases attributable to injecting drug use in Europe. In 2021, there were just five new infections related to drug use. How did they do it? They did it by decriminalizing possession of drugs for personal use, focusing on public health, investing in harm reduction, and putting communities at the center. Ghana recently removed criminal penalties for possession of drugs for personal use and is already seeing the benefits for public health. The evidence is clear: stigmatization kills and perpetuates the AIDS pandemic. Harm reduction and respect for everyone’s human rights saves lives and helps countries advance along the path that will end AIDS. What would an evidence-based, effective, harm-reducing policy framework for drug policy include? It would include decriminalizing possession of drugs for personal use, investing in HIV prevention responses, including harm reduction led by people who use drugs, including people who use drugs in policymaking that affects them, like our friends at INPUD who are represented here today. This is not radical. These approaches are all in line with the political declaration on HIV/AIDS, with the global AIDS strategy, with the Sustainable Development Goals, and with recommendations made by the High Commissioner for Human Rights. It’s out there in the mainstream. The excellent work by communities and countries leading the way has proven them. The question is, is the world, are we all of us here, bold enough to choose evidence over prejudice, inclusion over exclusion, laws that help over laws that harm? Shaping policies to ensure that no one is obstructed from access to vital health services is not a favor to one group. Protecting the rights of everyone is how we will protect the health of everyone. The stakes are too high for us not to be courageous. Thank you <iframe title="UNAIDS Executive Director at the 67th Session of the Commission on Narcotic Drugs, Vienna 14.03.2024" width="620" height="349" src="https://www.youtube.com/embed/E7XZ1DuIpF4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen>

Malaysia: (TBA)

Zimbabwe: As we gather here to take stock of progress implementing all drug policy commitments in the 2019 Ministerial Declaration, my country is deeply concerned at the worsening world drug problem destroying the life and future of young people. Disconcerting considering the challenges to recover from COVDI19. And climate change induced disasters that exacerbate vulnerabilities of our nations. The predicament of developing countries, particularly mine bearing the brunt of illegal economic sanctions from the West. We have been grappling with those since 2000, which limits investment, and debt relief initiatives. Reduces our capacity to mitigate illicit drug challenges. Our government reiterates its call for the immediate and total removal of illegal sanctions as echoed by regional authorities and UNGA resolutions deploring them as means of economic and political coercion against developing countries. We remain a friend to all and enemy to none. Fully support and valued coordinated international collaboration toward all multilateral efforts to overcome this challenge. We collaborate with international organisations and UNODC on the challenges of synthetic challenges in line with the Conventions. Police in Zimbabwe have made notable seizures and interdictions. Confiscating, arresting traffickers and disrupting criminal networks. Capacity strengthening for police, including equipment, technical assistance, from international partners to strengthen our capacity to counter trafficking. We are committed to confront this problem. National Task Force on Drugs and Substance Abuse to tackle this phenomenon through these pillars: Supply, harm, demand reduction, community integration, media, awareness, law enforcement, etc. Exemplifies our eagerness to collaborate to address the world drug problem. We pledge to convert a COVID19 facility into comprehensive drug treatment, rehabilitation and recovery facilities for individuals with SUDs. Evidence based and holistic approaches. Specifically to prioritise victim-centred approaches to address the needs of each patient. Establish a national drug and substances agency to coordinate efforts by different ministers, departments and agencies to eliminate drug and substance abuse in the country. To allocate a minimum 1.5m dollars toward the nation’s substance abuse programmes for 2024, managed by a special substance and drug abuse fund. Continued collaboration with UNODC in the fight against this scourge.

Laos (/ASEAN): Good afternoon. Mr chairman, distinguished guest, ladies and gentleman, on behalf of the association of South East Asian nations, I want to congratulate your excellencies including the chair. I seek the chair’s position to deliver a statement on behalf of the ASEAN member states. The world drug problem is complex and continues. Undermines the livelihood of communities and development of communities. Drug trafficking and abuse are bad because of a strong relationship between drugs and crime. Committing crimes to pay for drugs is an issue, and also crimes under influence of drugs. For that reason, our member states have maintained a zero tolerance policy, and we have committed ourselves to a vision of a drug free nation. We have a determination to address the world drug problem and promote a society free of drug abuse to ensure that all people can live in health, dignity and peace with security and prosperity. In drug policies moving forward ASEAN member states affirm our continued support to the CND as the principal policy making body of the UN on all matters of drug control so as to combat the spread of drug abuse. Through the CND process we reaffirm our commitments to address and counter the world drug problems in a comprehensive manner. We underscore the importance of complying with all of the current policies. We stress that the use of drugs for clinical purposes should continue and be based on strong protocols to prevent abuse or diversion. Methamphetamine tablet seizures show the scale of the issue. The COVID pandemic and strict border movements have created an opportunity for drug syndicates to innovate and change trafficking routes. Social media and e-commerce platforms are being used more by drug traffickers for encrypting messaging to promote and sell drugs. People are also using cryptocurrencies and law enforcement are having difficulty enforcing policies in light of these new strategies. Money laundering and human trafficking are also issues. Despite the challenges, ASEAN remain resolute in our commitment to counter the world drug problems and give people a safe and secure environment and meaningful lives. Because of this, we commit to a strong work plan moving forward. We are increasing commitment between ASEAN states and external platforms. We have established the ASEAN Narcotic Cooperation Center on this matter. We have maintained a zero tolerance approach. The annual drug monitoring report is an important resource. We have several platforms for intelligence sharing and coordination. Demand reduction – we have built an ASEAN portal to share resources. We are also scaling up treatment including community-based rehab and EBPs. We want to help people fully integrate into society and live a drug free life. ASEAN states are building capacity and innovative strategies to help farmers not return to illicit crops. We have seen some success in reduction of opiate cultivation by supporting rural farmers in other livelihood activities. We will continue to work together to effectively implement the workplan 2016-2025. We believe that countering the world drug problem is a shared issue and we must work collaboratively. We respect the sovereign rights of each state.

Uruguay: Uruguay: Given the new challenges we’re facing, with the exacerbation of some of the problems we face, it is clear that this midterm review requires us to be serious, committed and have political will in light of lessons learnt and identify improvements in our roadmap. Difficult reality that we face: breaches of basic rights, imperils many of those rights. This requires innovative responses from the international community. We’re concerned by the expansion of the phenomenon. Other variables must be taken into account in relation to production ,sale and consumption of drugs. We need scientific evidence on this – the harms on health are significant and extremely lucrative for the producers. When we don’t achieve our goals we must look for alternatives in a responsible, brave, committed fashion. We need a critical review of some of our concepts. With international organisations, civil society and UN agencies, we’ve discussed how drug trafficking becomes worse. Banning drugs as the only regulatory tool has not solved these key dilemmas and therefore has not led to the conditions that would allow to achieve the goals of the different conventions and commitments on drugs: social welfare and public health. We’re convinced of the need to restrict penalisation, stigmatisation, and the use of prison for minor offences. And we need to eliminate the death penalty in the countries that have it – this does not need more debate. Uruguay has said this many times: respect, promote, protect all human rights, fundamental freedoms, and the dignity of everyone, the rule of law, regarding the formulation and implementation of drug policies. Agenda 2030 on the SDGs must be taken into account, the goals should be part of our roadmap. For that reason, we pursue an international drug control system that would delve deeper into combating poverty, food safety, promoting health throughout life, peace coexistence and social inclusion. Success this week means new mechanisms, a new viewpoint, a different way to tackle drug problems. And which continue to concern all of us. The whole of the international community is affected by this and has to work together. We cannot do it individually or stay in words.

Belgium: We align ourselves with the EU statement. Thank you. I want to highlight some aspects that we consider indispensable to address the world drug situation. First, drug use is a multifactorial health issue. For a health system to address drug related issues it must incorporate specific requirements: evidence based practices, early detection, risk and harm reduction, treatment, rehab and social integration, and recovery, engaging with academia, civil society, and people with lived experience is crucial. Second, drug policies should be aimed at ensuring equality. Gender equality in particular. Data shows that women have less access to treatment and mothers are more likely to be stigmatised. A gender transformative approach is crucial. Third, we must do effective international cooperation with respect for international law and human rights and guided by interagency cooperation. These points align with Belgium’s national drug strategy. Trafficking presents a considerable challenge. In 2023 LE confiscated 21 tons of cocaine, record levels. Violence is also on the rise. Belgium’s investment in resources to thwart the elicit drug trade. 5 mobile scanners will help facilitate this to help find high risk containers. We are also going to implement background checks for port personnel. Our country prioritizes multi-disciplinary cooperation. Various stakeholders remain fully committed to destabilizing illegal activities. Cooperation is being strengthened with neighboring countries. Finally, we signed a treaty with the UAE which helped extradite someone. Belgium will remain at the forefront of confirming that people will be able to access important clinical drugs. We will provide financial contribution to UNODC to continue advocacy to help countries get access to controlled substances.

Netherlands: We align ourselves with the EU statement and recall international law, humanitarian law and the UN Charter in relation to the Russian aggression on Ukraine and all other conflicts. The 2023 WDR demonstrates an upper trend in people with drug dependence. Treatment is failing to reach those who need it. Drug trafficking networks fuel illicit markets, harm individuals, societies, environment, economies alike. We need more effective and innovative ways for progress – identify good practices and learn from mistakes. Exchange data and scientific results to improve approaches. International cooperations is fundamental, including with the scientific community and civil society. In defining the direction for the next few years, we will advocate for human rights, national drug law reform: alternatives to coercive sanctions, abolition of the death penalty, decriminalisation of drug use. Evidence based interventions and a balanced approach to drug policy, focusing on preventing drug use and protecting health on one hand; on the other hand countering trafficking. Using drugs is not part of a healthy lifestyle. We are strongly committed to prevention.m We need to ensure voluntary access to quality treatment and care, risk and harm reduction interventions and reducing stigma. Addiction problems in the Netherlands are important so we created a specific followup body on the matter. We need stronger border control, protect police on the frontlines, and reduce corruption influence. Remove the conditions conducive to criminal activity whilst enhancing resilience against criminal influence. We created a multi agency programme with millions of euros. We welcome pledges for action.(…) Support to municipalities to define and implement prevention programmes adapted to local context. Avoid networks recruiting young people, fulfilling our pledge of placing the health and safety of all members of society at the centre of our efforts.

Czechia: Thank you to the UNODC. I look forward to a dialogue on the emerging challenges. The world drugs situation changes rapidly. Inequality and social and economic disparities drives and are driven by the drug situation, threatening health and human rights. We must admit that we are failing in our efforts to improve the situation. The current system is based on three drug control conventions. The original aim was to help health and welfare. But current systems are punitive, aiming to suppress the market. Many countries have unbalanced policies. We spend millions to curb drug supply and demand, but data shows there has been an increase in the scale of drug trafficking over past five years. The number of people using drugs has also increased. We continue to face serious human rights violations including death penalties, extrajudicial killings and arbitrary arrests for drug use. There is a lack of access to treatment, recovery, and harm reduction services. Synthetic drugs are increasingly dominant. Globally there is an overdose crisis. This requires an immediate response to excelerate our commitments. We must promote our common efforts and policies based on a public health approach and human rights. We believe it’s time to change our understanding of the regime. Policies should protect the health of individuals and society – so we must interpret them in the understanding of latest scientific evidence. This should help promote the harm reduction approach which we understand as interventions to reduce drug related harms but also a philosophy. It also includes reforming drug policies including decriminalization, depenalization, and strengthen capacity and funding for harm reduction, prevention, and voluntary treatment. I want to reiterate our strong commitment to human rights law. Cooperation with academia, civil society, and people with lived experiences are also important. We must mainstream harm reduction policies by using scientific evidence. How much more evidence is needed to show that the war on drugs is failing? We want to increase the availability and access to treatment for people who use drugs and the controlled availability of some substances.

Italy: We align ourselves to the EU statement. In a national capacity: when I visited an Italian therapeutic community recently, I talked with a girl that is now 18 years old. In half an hour she told me the story of her life. (…) Out of boredom and emulation, she started using cannabis derivatives. When she was 15, she moved to cocaine and crack. When she was 16, she got arrested for serious crimes committed to buy psychoactive substances. Then, the therapeutic community became an alternative to incarceration. She wasn’t glad. She struggled to follow the rules of the new game. A game aimed at leaving addictions behind and gaining freedom. Today, she’s one of the guides of a group of girls that face life with courage. Stories like these. They deserve institutional answers. Italy believes in a balanced approach. We must intervene proactively in order to contrast the production and trafficking of drugs at global level. Disrupting the roads that cross seas and continents. This is the teaching among others of Giovani Falcone. This was a brave magistrate. A law enforcement officer. Doing this in one of the most exposed areas of the supply chains. Prevention, treatment, and rehabilitation services must be provided to everyone. We’re against the use of all drugs. We don’t believe that in a legal system there is a right to use psychoactive substances. Instead, there is a duty to act before the spread cause irreversible damage. We’re strengthening our prevention activities to contain the spread of synthetic drugs, such as fentanyl analogues that Italy scheduled in 2020. In our country, we don’t have an ongoing emergency but we want to be ready. We learn from our American colleagues, through the global coalition to address synthetic drug threats. Look favourably on the entering into force of the EU Drugs Agency, strengthening the European early warning system. Through the collaboration of all ministers, we developed an action plan for fentanyl. The keywords for us in this period are: informing, training, raising awareness among the categories at risk. Enhancing controls to prevent the introduction of substances on our territory and its diversion to non-medical use. Monitoring the web to suppress online trafficking. Activating the emergency services for specific analytical research in case of overdose and so on. (…) For the safeguard of our citizens. Early prevention is our starting point. PRevention related activities must be strengthened, aimed at increasingly younger targets, addressing not only psychoactive substances but all pathological addictions. This is a winning strategy inside and outside national borders. Those of us involved in treatment and prevention know that if we treat a disease you can win or lose – treating a person means that you win. Gratitude to the Pompidou Group, which reaffirms that it opposes the death penalty under any circumstance without exception. Committed to promoting the rights of all and the enhancement of treatment services. The right to life must be granted to everyone. With a view to enhancing the implementation of all drug policy commitments, I pledge for Italy to fund UNODC to enhance prevention activities through technical support providing 120,000 euros for the Friends in Focus programme, peer to peer programme in the Western Balkans -and considering another support for UNODC’s Prevention Framework.

Ghana:Chairperson, I have the honour to deliver this statement on behalf of the Africa Group. At the onset, the Africa Group aligns itself with the Statement of the Group of 77 and China. The Group extends its warm congratulations to H.E Ambassador Philbert Johnson, Permanent Representative of Ghana on his election as Chair of the 67th session of the CND as well as to other members of the Bureau on their election. We thank the UNODC Secretariat for the excellent preparations for this session and assure you of our full support. The Group further congratulates Ambassador Johnson for presiding over this important session tasked with conducting a stocktaking review of the progress made in the implementation of the 2019 Ministerial Declaration and conveys its gratitude for his tireless efforts and leadership in preparing for this High-Level Segment, including his constructive on behalf of Africa as the Chair of the CND, to reach a consensus on the Outcome Document and uphold the Vienna Spirit. The Group also expresses its support for the Chair’s innovative “Pledge4Action” initiative aimed at mobilizing commitment towards concrete and impactful actions to address and counter the world drug problem. Chairperson, The Group commends the Executive Director of the UNODC, Ms Ghada Waly, for her able leadership in guiding our efforts to address and counter the world drug problem. The Group also commends Ms Waly for the UNODC Strategic Vision for Africa 2030 and calls for sufficient funding of the Strategy. The Group further urges the UNODC, relevant partners and donors to provide sufficient financial and technical support to African countries, tailored to their needs and priorities, to ensure the successful implementation of the mandate of the Commission in pursuance of the SDG Agenda 2030 and 2063 AU Agenda. The Group emphasizes that addressing and countering the world drug problem is a common and a shared responsibility of all UN member states and reiterates its commitment to the 2009 Political Declaration and Plan of Action; the 2014 Joint Ministerial Declaration; the 2016 UNGASS Outcome Document and the 2019 Ministerial Declaration (as well as its 2024 Mid Term Review Outcome Document Chairperson, The Group notes with appreciation the efforts of the African Union to craft a Common African Position for the Mid-term Review of the 2019 Ministerial Declaration, drawing attention to the challenges faced by the continent to improve the health, security and socio-economic wellbeing of its people, and further welcomes the African Union Plan of Action on Drug Control and Crime Prevention (2019-2025) . The Group notes with grave concerns the persistent disparities on progress made in ensuring the availability, accessibility, and affordability of controlled substances for medical and scientific purposes, particularly for the relief of pain and palliative care. The Group urges all Member States, the UNODC, and the private sector, especially the pharmaceutical industry, to take concrete actions to ensure access, availability and affordability of controlled substances for medical and scientific purposes and remove any barriers in this regard. Chairperson, The Group is concerned over the interlinkages between drug trafficking and other forms of transnational organised crime including corruption, illicit financial flows, cybercrime, and terrorism and calls for enhanced sub-regional, regional and international cooperation, including technical assistance and capacity building for law enforcement agencies, to counter this scourge. Chairperson, The Group takes note of the decision to delete cannabis and cannabis resin from Schedule (IV) of the 1961 Convention and placing it under International Control in Schedule (1) based on the WHO recommendation, while we recognise that Member States shall have the right to further exercise domestic control in accordance with Article 39 of the 1961 convention in this regard. The Group expresses concern regarding the increasing threats caused by synthetic drugs and their impact on the illicit drug market and, urges all Member States to decisively tackle this challenge. The Group continues to note with concern the harmful effects of the increasing nonmedical use of pharmaceutical opioids including Tramadol and invites Member States to collect and share data to facilitate the consideration of placing of the substance under international control to prevent its diversion for illicit use while ensuring its access and availability for medical and scientific purposes. The Group also denounces the online illicit trafficking of drugs, especially on the Darknet and increased illicit trafficking in precursor chemicals and synthetic drugs. The Group urges Member States to effectively counter these new and emerging challenges. We reaffirm the role of the CND as the principal policy making body of the United Nations in drug control matters, and our support for the efforts of the relevant UN entities, especially the treaty-mandated roles of the INCB and the WHO. The Group commends the Executive-Director for ensuring equitable geographical representation and gender balance are fully incorporated in the recruitment policy of UNODC, particularly at the senior levels. In conclusion, we reaffirm our resolve to review in 2029 progress made in implementing all our international drug policy commitments and undertake to accelerate and improve their implementation in the period from 2024 to 2029.

Kyrgyzstan: Thank you. I would like to outline our position, progress, and proposals. I would like to reiterate our commitment to uphold measures outlined in the international conventions. I’d like to inform you that Kyrgyzstan has achieved positive outcomes and has significantly expanded our international cooperation. A new law on narcotic substances, psychoactive substances and their analogues and precursors was developed along with an anti-drugs policy and an early drugs warning system. Thanks to our meticulous efforts our legislation is fully aligned with international law and takes on board the recommendation of the relevant bodies. Preventative bodies have allowed us to reduce drug use. Referrals to anti-drug programs have fallen steadily over the last years. We have implemented harm reduction programs particularly in regards to infectious disease. Quantities seized have risen, which shows us that we’ve combatted organized crime groups using the controlled delivery method. We have successfully taken action against controlled drug crime groups. We’re also taking action against money laundering and now have good policies to do so. We are preventing the use of internet and messaging applications for drug sale and advertising. We have reduced the land areas where cannabis are grown and using drones we will soon be able to reduce this even more. All of these facts and others show that Kyrgyzstan is doing a great job. We also note that drug trafficking and abuse have undergone structural changes. The spread of new psychoactive drugs has been a challenge to Kyrgyzstan and the international community alike. Better info exchange on these substances will help us put them under control along with their precursors and substitutes. Especially in countries with a developed chemical industry we need to pay close attention to precursors and substitutes. We believe that IT can be used to address this. Chairperson, we would like to support your initiative. We believe that drug markets are expanding in size and assortment of drugs on offer, illegal drug sales have reached record levels. Synthetic opioids and non-medical use pose a major hazard. Health outcomes have reached troubling levels. We pledge to establish an NPS early warning system by the end of 2025. Our system will focus on monitoring and identifying new substances that can present a risk to health and security.

Romania: Firstly, I want to reaffirm our commitment tot the Conventions and to the acceleration of the implementation of all drug policy commitments. In particular, the 2016 Outcome Document. Full cooperation with CND and all UN bodies, the WHO, INCB, show my appreciation for all activities and initiatives in recent years to further international cooperation. Through data exchanges, which is key to combating and preventing the drug phenomenon. We aligned with the EU statement delivered today. The world drug situation has worsened. We face challenges previously unforeseen. The recent pandemic led to new dynamics in the drugs phenomenon, the use of the darknet, new developments in synthetic drugs, and NPS. The diversion of non-scheduled chemicals and the proliferation of designer precursors too. Controlling precursors is challenge to an extent not seen before. Proactive approach to anticipate substances that could be used in drug manufacturing. We need to enhance forensic capabilities and warning systems to identify new dangerous substances. International scheduling remains the most effective measure. We support the addition to the new substances in the EU legislation as adopted in the EU Legal Affairs (…). We are part of the Global Coalition to Address Synthetic Threats initiated by the US. We have made a substantial contribution to the EWS of the EU. We also contribute data collection and processing instruments. In addition to supply reduction, we need a commitment to prevention. Special emphasis on protecting children and youth and vulnerable members of our society. To combat this scourge in our schools, we have action groups set out following the adoption of a cross-ministerial plan. In 2023, the Supreme Council of National Defence on the use of drugs by young people and students, a measure of security was adopted bringing all together relevant authorities, including ministers of education and health, which under Internal Affairs, improve interagency cooperation to tackle drug use among students. Romania calls for closer and integrated cooperation at the international level to accelerate drug policy commitments and fight drugs phenomena. We call on states to gather scientific data on their effectiveness and efficiency in addressing and countering the world drug problem. We are committed to proportionate sentencing for drug related offence.s All countries should adopt drug policies that uphold the rule of law, proportionality, human rights.

Nigeria: I want to congratulate you on your election and the secretariat on their excellent preparation. Nigeria embraces the goals and objectives of the three international drug conventions. We will take a strong stance against illicit cultivation and production of drugs. The 2023 world drug report showed the drug supplies were at record levels. There are intersecting global crises which are challenging law enforcement response. The introduction of synthetic drugs has been an issue. Nigeria has continued to adopt hard drug control policies to respond to emerging realities. The revised fourth plan 2021-2025 combines law enforcement and promotion of public health while employing inter-agency and global collaboration. Nigeria continues to leverage this document to advance the counter-narcotics campaign. Nigeria through NDLA has continued to intensify its operations to counter drug abuse and drug trafficking with international collaborations. We aim to seize illicit drugs and bring justice. We have continued to prioritize prevention, treatment, and recovery. We want to help people rebuild their lives. We target people who have not started using drugs, those who are using drugs but don’t have physical symptoms, and those who are having problems as a result of drug use. This is a balanced approach to drug use. Despite implementation of our plan, trafficking of drugs and its abuse has persisted. We maintain that legalization of non-medical use of cannabis is a violation of the drug control treaties. The trafficking of non-medical drugs remains a challenge despite our domestic control efforts. We wish to re-echo our position of needing to change the control of substances including tramadol.

Singapore: The world drug situation is worsening. In east and southeast asia, we have seen an increase in synthetic drugs, particularly methamphetamine. Trafficking in the Golden Triangle is increasing significantly. We are concerned with such developments and reiterate our commitment to a vision for a drug free ASEAN and affirm the ASEAN statement to counter the world drug problem. We see issues in other regions too. This is a timely opportunity to calibrate our approaches in conformity with the COnventions. Singapore adopts a holistic harm prevention approach aimed at addressing supply and demand. In 2023, 9/10 persons supported our drug free position. To give our efforts a further boost, we set up a youth committee focused on effective engagement strategies supported by parents, school and the community. Appointed Singapore Drug-Free Champions to promote drug education among youth. Prevention reduces harm in our communities. As well as rehabilitation and enforcement resources. This matter is of shared responsibility. Singapore commits to the Convention and acknowledges the important mandate of the CND, INCB and UNODC in tackling the world drug problem. CND in particular plays a crucial role as a policymaking body in the UN with primer responsibility on drug related matters, foster international dialogue and coordinating joint action against drug problems. Singapore is, as a member, committed to supporting CND throgun policy discourse, capacity and scientific expertise. I pledge for Singapore to sponsor a chapter on WDR examining the societal impact of illicit drug use globally, which will enhance our understanding and aid our collective efforts to address the harms of drugs on our communities. Singapore will jointly organise a high level side event on collecting high quality reliable data. I invite you to attend. IN conclusion, the challenges we face are complex. The challenges we face should always be responded to through evidence within the Conventions There’s no one size fits all in relation to the WDR. Approaches in a region may not work in another region. Each country’s domestic circumstances must be respected.

Namibia: Thank you. You have Namibia’s full support. I commend the UNODC’s secretariat for excellent preparations. My delegation aligns itself with the statements given by the African group. Namibia recently nominated their second national drug control group. This group is critical for the implementation of the 9 pillars of the master plan: the implementation of measures to advance drug demand reduction, addressing health issues associated with drug use and in particular the use of injectable drugs, the implementation of alternative measures to incarceration for drug use, promotion of proportionate drug and age sensitive sentencing, facilitation of access to controlled substances for medical and scientific purposes while preventing diversion, implementation of measures to reduce the supply of drugs along with countering drug trafficking, institute measures to prevent organised crime associated with illicit drugs trafficking, and strengthening international and regional cooperation based on the principle of common and shared responsibility, The NDCC is comprised of many varied stakeholders to ensure an effective multi-sectoral approach to address the global drug problem. Namibia confiscated $50 million Namibian dollars of drugs including cannabis, cocaine, crystal meth, and ecstasy. Cannabis maintains the top spot with a marginal increase of 6% compared to last year. The 2023 world drug report shows that 40% of SUDs are cannabis use disorder for the age group < 34 years. Namibia maintains its stance that the international drug control conventions constitute the cornerstones of the international drug control system. The importance of achieving targets and goal setting in the 2009 political declaration and plan of action, sustainable development goals as well as the 2016 UNCAS. Namibia will conform with the chairperson’s plan. Namibia commits to finalise the enactment of the two new pieces of legislation, legislation on drug control and the prevention and treatment of substance use by the end of 2025. We will build a centre for youth by the end of 2025.

Portugal: Align ourselves with the EU statement. (…) We must turn the tide by upholding the principles of the UN Charter, international law, and international humanitarian laws – fostering dialogue between warring powers. Unrelenting opposition to the death penalty in all circumstances. Opportunity to take stock of progress since 2019. MS, UN bodies, international organisations and civil society must accelerate efforts to implement all drug policy commitments, in particular the UNGASS 2016 Outcome Document, which must be addressed with innovative measures in order to (…). We welcome the adoption of the Outcome Document at this midterm review and its emphasis on new approaches to face the next years. We welcome the resolution of the HRC adopted in April on drug policy and human rights and the report of the OHCHR on the matter. We commend the synergies within the UN system. Important guidance on how to move towards more health and human rights based policies. Ensuring access to evidence based prevention, detention, intervention, risk and harm reduction, treatment and social reintegration measures in a non discriminatory manner is vital to protect the most vulnerable, reduce stigma and promote participation. Importance of meaningful comprehensive structures civil society statement in formulating and implementing drug policies at all levels. The evidence knowledge of our approach over the past twenty years shows how to prevent public use and protect health within the framework of decriminalisation of use and possession of drugs while (…). Effectiveness of the Portuguese model is clear. Since 1999, problematic consumers have reduced by ⅓. HIV among people who inject drugs declined by 98%. We stand ready to promote more health oriented and human rights based drug policies and there’s positive efforts towards the goals of the Conventions and all relevant instruments in particular human rights with a view to enhance implementation of all drug policy commitment, I pledge for Portugal, increasing inpatient capacity and reducing waiting times by 2028.

Thailand: Thailand is fully committed to fulfilling the fundamental aims of the three international drug control conventions, the 2019 ministerial declaration, and the 2016 UNCAS outcome document. Aligned with these principles, Thailand has made a recent law reform on the new narcotics code in late 2021 towards health-based approaches to better addressing drug situations of the country. Mr. Chairman, ladies and gentleman, our prime minister will collaborate with various sectors to eradicate illicit drugs from Thai society. We will follow the principles of transforming drug users into patients which encourages drug users to seek treatment. The goal is to increase the number of rehabilitated individuals who can reintegrate into society and contribute to the workforce. Manufacturers and traders in the illicit drug trade will face legal consequences including the confiscation of assets aimed at disrupting the drug trafficking cycle. The government will also talk with neighboring countries to control drug supply in Thailand with the goal of ending drug trafficking. The government will also work to allow cannabis for only medication treatment and research purposes, ensuring the legislations are in place to prevent its use for recreational purposes. I express my deep appreciation to the work of the UNODC to support relevant clients and activities. Acknowledging more complexity and severity of the drug problem needs a high level of cooperation. Thailand will consider making more contributions to the UNODC in the near future. With our standing success on alternative development, Thailand has long underscored the importance of a development approach in drug policy by promoting the UNODC’s policies to reduce illicit crop proliferation. I pledge for Thailand to tangibly reduce the severity of drug problems in the country within a year with appropriate treatment and rehabilition. We will also reduce trafficking and increase international cooperation at all levels to address challenges in the Golden Triangle to ensure a safe society.

Iran: Recall genocide against the people of Gaza. Measures are required to avoid famine and starvation. In line with the implementation of the 2019 Ministerial Declaration and the international treaties and conventions, Iran has adopted a balanced strategy in the field of drug control over the past 5 years, promoting public security and health as follows: 1) Strengthening the fight against drug supply and transit enhancing intelligence measures at the borders and crossing points and intensifying the fight against money laundering. 4450 tonnes of drugs from afghanistan were seized through the martyrdom of 15 members of law enforcement and efforts by our forces. Iran has not witnessed considerable reduction in drug trafficking from afghanistan. In the past 15 days, 2 cases of drug seizures made in the course of two operations 4800 kilos of drugs to a certain European country. Iran has witnessed the rise in methamphetamine seizures from afghanistan. 2) Formulating and implementing the comprehensive document on primary prevention with maximum coverage, knowns as Helpers of Life, in families, education settings and communities. 3) Formulating and implementing document on treatment and harm reduction through development of treatment centres, involvement of NGOs and private sectors, 7200 centres diversifying treatment methods including pharmaceutical and psyco-social interventions, access to controlled medicines, offering harm reduction programmes, controlling the spread of HIV AIDS and hepatitis. Iran scientific achievements left to the establishment of a regional centre in Tehran to study drug use disorders with UNODC. 4) Community based approach in demand reduction, empowering NGOs and establishing NGO of Helpers of Life with benefactors from all provinces. Bearing in mind Iran’s fight against the WDP and related challenges such as violence, terrorism, influx of displaced persons, illegal migrants, armed confrontation, financial and human casualties of conflict, I seize the opportunity to present our pledge: requiring continued and effective implementation of drug control projects in the region away from political considerations and restrictions in allocation of funding and resources, lifting the cruel and unilateral sanctions. 2) Cooperation with Iran to strengthen the global fight against illicit drug activities based on the principle of common and shared responsibility. 3) sharing successful lessons, demand reduction,scientific exchanges, activities in darknets, mechanisms to intervene. 4) Opposition to the reconsideration of the global drug control regime aimed at legalisation tantamount to the destruction of humanity’s legacy in this arena. 5) Necessity of adherence of all states for the implementation of the three drug conventions and the authority of the drug control regime.

Senegal: We endorse the statement made on behalf of the African group. And we would also add: the scope of the drug problem poses a lot of issues including political stability and economic development. We would like to counter illicit trafficking of drugs. We have adopted the three UNODC declarations and see them as a cornerstone. We also signed up to the joint ministerial declaration after CND in 2014 and the outcome document in 2016. We recently signed the 2019 ministerial declaration on strengthening actions conduction on the regional and international levels to show our commitments to addressing the world drug problem. We implemented an inter-ministerial committee to define national policy to combat drug trafficking and abuse. This has led to the adoption of a national strategic plan which has now been renewed. We have achieved an increase in drug seizures especially in the maritime area, the creation of a national office which suppresses crime related to drug trafficking, an increase in the availability of controlled drugs for clinical purposes, the development of an addiction clinic, the creation of an addictology degree, the development of a harm reduction program including needle exchanges and OAT, the implementation of actions involving prevention, an internet platform to raise issues of drugs among young people. These items are underway and we have three major projects that will receive government funding: a project to construct buildings for de-addiction institutions, a project for a research program, and an alternative development program. We pledge to implement those projects which will help us more effectively combat the scourge. In the ordinary meeting we have an item on these commitments.

Pakistan: Align ourselves with the statements by the G77 and Asia-Pacific groups. The Outcome Document signals strengthened resolve to tackle the world drug problem. Commend you for leading the challenging situations. Our consensus creates renewed political momentum to enact the Conventions. Pakistan contributes greatly to counter illicit drugs: demand and supply reduction, regional and international cooperation, research and development, access to controlled medicines. Encouraging results internationally acknowledged including by UNODC. Suffering of illicit drugs. Endanger the health and safety of our people. Countries who contribute to demand should strengthen their response, it would benefit us all in addressing the world drug problem. Effective implementation of Convention will help address and counter the world drug problem and promote health and welfare of our people. Concerned for legalisation of non-medical and non-scientific use of cannabis. We believe as the INCB that this contravenes the Conventions. We call on the INCB to ensure full compliance by Member States. Pakistan is committing to protecting human rights according to its national laws. Excessive focus on human rights should not limit us in countering the world drug problem. In line with our obligations under international law, our judicial and health systems need strengthening. Occupation and conflict also affects people in this way. We need greater solidarity with the people of Palestine. In view to enhance implementation of all drug policy commitments and addressing challenges related to availability of data, lack of treatment, and diversifying drug markets, Pakistan will 1) establish a national counternarcotics centre within the next 12 months to regulate and synergise antinarcotic efforts. 2) Build a state of the art addiction rehabilitation and reintegration centre within 12 months. 3) Extend the anti-narcotic force addressing emerging locations and supporting human resources (…)

Turkmenistan: (TBA)

Cuba: The WDP cannot be tackled by domestic policies alone. It’s a global problem to face together. This is why we have the political will to deal with the international community with ideals to combat this problem. More important than ever to acknowledge and implement the principle of joint and shared responsibility to deal with this problem within international law and the principles of the UN Charter. Progress towards strengthening cooperation to effectively tackle the WDP. Far from disappearing, it’s getting worse. The impact and serious consequences of the scourge will not be solved if it’s a politicised issue or drugs legalised as inoffensive substances in different regions and countries. Multilateral cooperation, international organisations and UN programmes in accordance with their mandate, and UNODC, are all of vital importance to achieve our goals. We ratify Cuba is not a transit or producing or money laundering zone or a refuge for international criminals. Drugs come to our coasts and through gangs located abroad. We have a zero tolerance policy to trafficking and provide differentiated treatment for use for a public health perspective to tackle and treat it. We believe this is required because it’s a multifactorial problem: education, families have a role to play. But we need this bulwark, and continue to work in our communities. We have greater participation in grassroots organisations with students, schoolchildren and other civil society elements. With a great deal of effort Cuba has made trafficking, consumption and production of illicit drugs isn’t a significant problem in our country, so our country is not a transit country for trafficking. We don’t have many resources to fight this because of the financial blockade imposed arbitrarily and unilaterally by the US, which call us a terrorist state. This high level segment will reaffirm the political commitment of states and other actors to the three drug conventions and the international drug control system. Cuba aspires to achieve a society free of illicit drugs. Essential for sustainable social development and the wellbeing of our people.

Ecuador: It is an honour for me to participate in the representation of the government of Ecuador in this very important multilateral meeting. The path that has brought us to this midpoint in 2024 has shown some progress and some retreats with regards to drugs which I think is to be expected given the global reach of the drug problem. In order to be effective we have to have common but shared responsibilities according to the UNODC drug reports. The international drug community has co-responsibility and should join together to tackle the serious consequences of this phenomenon. In the case of Ecuador, a country which is a transit country, a victim of producers and consumers, this impact has weakened public security, institutional strength, and has even undermined democracy. There has been indiscriminate violence and immigration to other countries in pursuit of new opportunities. On the 9th of January 2024 under our President we chose decree 111 to safeguard state security. This decree acknowledges the existence of a domestic armed conflict and identifies 22 terrorist groups mainly funded by drug traffickers and illegal mining. Since implementing this, the rate of violents deaths has been reduced by 66% and we have reduced criminal activities in our prison system which has combats our society falling apart. We conducted 148,000 operations during this period with LE. With the support of the international community we are fully combating drug trafficking, corruption, and organised crime. The measures adopted by the government of Ecuador within the phoenix plan are being implemented with full respect for international instruments following humanitarian law, etc. Regarding progress made in drugs policy during this midterm review, Ecuador would like to highlight the coordinated actions undertaken by state institutions to deal with activities related to drug trafficking and I’d like to highlight the active support of civil society, regional, and international organisations. I’d like to highlight the first international meeting on the management and disposal of precursors which took place in 2023. Ecuador believes that peace and security lead to development. From this point of view, combating drugs, drug trafficking and transnational organised crime cannot be successful unless we create opportunities for a young population such as Ecuador’s for employment and education. That is why in barely 100 days, four urgent financial laws were approved to strengthen economic stability. As a result, in 60 days we created 60,000 jobs for young people. It is only if we create these opportunities that young people can no longer be attacked by criminal groups. Ecuador expresses its thanks to UNODC and other countries for this support. This support strengthens our ability to do public policies with a human rights approach aligned with the human development goals…secondly, with regards to improving the implementation of all our international commitments regarding drug control considering all efforts to reduce demand, the secretariat for the institutional committee will be working with different ministries and civil societies. Ecuador commits to a new development strategy which is comprehensive and sustainable. We will have a geographic model of vulnerable areas and we will take into account the characteristics of different areas. It will include training and education. This will be implemented in 14 months to foster sustainable development of the people who live there.

Jordan: Support efforts by Ms Waly and her team at UNODC. We endorse the G77 statement and the Asia-Pacific Group statement. We meet at the beginning of the month of Ramadan. A month of peace. But the people of Gaza are not enjoying peace. This cannot continue. We cannot continue subjecting women and children, and the inhabitants of Gaza, to hunger. We will spare no efforts to get aid in and the only way is to cease the policies whose aim is starving the people of Gaza. We will continue to have the sacred nature of life respected in Gaza. Peace is Jordan’s regional strategy, for Palestinians and Israelis alike. The only way to do that is 1967 borders for a Palestinian state. Chair, we know the scourge of drugs poses threat to societies, depletes resources…we need to step up international cooperation to combat the drug problem and come up with solutions to protect society. The challenges are of increasing scale owing to technologies which are having and impact on the methods used by traffickers. We have the problems of counterfeit medicines like captagon. Our view is that the Conventions provide a reference framework for efforts. We are committed to implementing the content of the 2019 Ministerial Declaration. We are committed to the outcome document of the 2016 UNGASS on the world drug problem. Our region is a troubled region and organised crime groups profit from that state of affairs. Our law enforcement bodies work persistently and continuously to combat drug trafficking and this testifies to the efforts that we undertake in order to address the challenges we need to address all aspects of the world drug problem. That’s how JOrdan works, implementing a national programme to combat illicit drug trafficking. Measures such as: national strategy to combat drugs for the period 2021-2025, introduced amendments to legislation on drugs and the aim here is to secure international changes into the national level, measures to address the drug problem at the point of use, trafficking… Countering internet trafficking. Also a container programme raising awareness on the dangers of drugs. National plan to raise awareness involved in civil society organisations and ministries. Travelling exhibition to raise awareness. Participated in activities by the European Drug Surveillance Centre and Pompidou Group. Jordan has made progress in providing free of charge treatment to addicts. We have set up a system whereby young people are treated for drug addiction in private hospitals at the expense of the Ministry of Health. This meeting serves to step up efforts to protect our societies and children. We reiterate our commitment to work with all countries and international organisations in combating drugs and underscore CND’s principal policymaking role in drugs.

INTERPOL: (…) The role of INTERPOL in supporting the implementation of Conventions has been recognised since their inception. Since then, the world drug problem has evolved and worsened. Fortunately, the power of international cooperation through INTERPOL has also increased. In a recent example from December 2023, a fugitive from Paraguay was arrested. For Paraguay, this arrest involved the seizure of assets in excess of 100,000,000 dollars. INTERPOL can aggregate information and provides essential capabilities like a drug analysis file. (…) Over the last few years, law enforcement agencies have seized record quantities of cocaine, cannabis and other substances. Created a pharmaceutical drug database. Operation Trigger 9, demonstrated convergence between illicit drug crimes. Although firearms focused, seizure 400 tonnes of precursor chemicals. Collaboration with INCB, UNODC. Participation in CRIMJUST and AIRCOP has facilitated cooperation targeting illicit drug related activities. Also relevant in relation to the Global Coalition on Synthetic Drugs. First resolution mentioning INTERPOL from (…). We support countries upholding their commitments to the Treaties and the 2019 Ministerial Declaration. We will continue to foster cooperation between member countries to coordinate and tackle the world drug problem.

CND Blog

Item 3. High-level segment (Thursday afternoon)

Leave a Reply Cancel reply